<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:23:10Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9585146" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9585146</identifier>
        <datestamp>2022-10-22</datestamp>
        <setSpec>scirep</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
              <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
              <journal-title-group>
                <journal-title>Scientific Reports</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2045-2322</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9585146</article-id>
              <article-id pub-id-type="pmcid">PMC9585146</article-id>
              <article-id pub-id-type="pmc-uid">9585146</article-id>
              <article-id pub-id-type="pmid">36266402</article-id>
              <article-id pub-id-type="publisher-id">21246</article-id>
              <article-id pub-id-type="doi">10.1038/s41598-022-21246-9</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Epigenetic impact of a 1-week intensive multimodal group program for adolescents with multiple adverse childhood experiences</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Kaliman</surname>
                    <given-names>Perla</given-names>
                  </name>
                  <address>
                    <email>pkaliman@uoc.edu</email>
                    <email>pkaliman@wisc.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Cosín-Tomás</surname>
                    <given-names>Marta</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Madrid</surname>
                    <given-names>Andy</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Roque López</surname>
                    <given-names>Susana</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Llanez-Anaya</surname>
                    <given-names>Elkin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Papale</surname>
                    <given-names>Ligia A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alisch</surname>
                    <given-names>Reid S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Davidson</surname>
                    <given-names>Richard J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution>Center for Healthy Minds, </institution><institution>University of Wisconsin-Madison, </institution></institution-wrap>625 W. Washington Ave., Madison, WI 53703 USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.36083.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 6620</institution-id><institution>Universitat Oberta de Catalonia (UOC), </institution></institution-wrap>Rambla del Poblenou, 156, 08018 Barcelona, Spain </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.434607.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 3517</institution-id><institution>ISGlobal, </institution></institution-wrap>Barcelona, Catalonia, Spain </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5612.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2172 2676</institution-id><institution>Universitat Pompeu Fabra, </institution></institution-wrap>Barcelona, Catalonia, Spain </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.466571.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 6246</institution-id><institution>Centro de Investigación Biomédica en red en Epidemiología y Salud Pública (Ciberesp), </institution></institution-wrap>Madrid, Spain </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution>Department of Neurological Surgery, </institution><institution>University of Wisconsin-Madison School of Medicine and Public Health, </institution></institution-wrap>Madison, WI 53792 USA </aff>
                <aff id="Aff7"><label>7</label>Association Innocence in Danger Colombia (IIDC), 33 Avenue Saint Charles, 34090 Montpellier, France </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.442204.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0486 1035</institution-id><institution>Masira Institute, </institution><institution>University of Santander (UDES), </institution></institution-wrap>Bucaramanga, Colombia </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>20</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>20</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>12</volume>
              <elocation-id>17177</elocation-id>
              <history>
                <date date-type="received">
                  <day>27</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>9</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">Adverse childhood experiences (ACEs, i.e., abuse, neglect, household dysfunction) represent a potential risk factor for a wide range of long-lasting diseases and shorter life expectancy. We recently described a 1-week residential group program, based on mindfulness training, artistic expression and EMDR group therapy, that significantly reduced PTSD-related symptoms and increased attention/awareness-related outcomes in adolescent girls with multiple ACEs in a randomized controlled study. Since epigenetic mechanisms (i.e., DNA methylation) have been associated with the long-lasting effects of ACEs, the present report extends these prior findings by exploring genome-wide DNA methylation changes following the program. Saliva samples from all participants (n = 44) were collected and genomic DNA was extracted prior (T1) and following (T2) the intervention. Genome-wide DNA methylation analysis using the MethylationEPIC beadchip array (Illumina) revealed 49 differentially methylated loci (DML; <italic>p</italic> value &lt; 0.001; methylation change &gt; 10%) that were annotated to genes with roles in biological processes linked to early childhood adversity (i.e., neural, immune, and endocrine pathways, cancer and cardiovascular disease). DNA sequences flanking these DML showed significant enrichment of transcription factor binding sites involved in inflammation, cancer, cardiovascular disease, and brain development. Methylation changes in SIRT5 and TRAPPC2L genes showed associations with changes in trauma-related psychological measures. Results presented here suggest that this multimodal group program for adolescents with multiple victimization modulates the DNA methylome at sites of potential relevance for health and behavioral disorders associated with ACEs.
</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Psychology</kwd>
                <kwd>Biomarkers</kwd>
                <kwd>Health care</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par2">The exposure to chronic and severe negative life experiences during early childhood is associated with the development of a host of physical and mental health problems later in life<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Adverse childhood experiences (ACEs) include physical, sexual and verbal abuse, physical and emotional neglect, witnessing violence at home, a family member suffering from addictions, mental health issues or incarcerated, and losing a parent to separation, divorce or other reason<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Children who have experienced four or more ACEs are more likely to develop long lasting health issues such as diabetes, heart disease, overweight or obesity, cancer, respiratory disease, mental health conditions, alcohol and drug abuse, interpersonal and self-directed violence and sexual risk taking<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p>
              <p id="Par3">There is growing evidence suggesting that epigenetic modulation is one of the molecular mechanisms through which stressors interact with the genome. Epigenetic information regulates gene expression and, although relatively stable, the epigenetic landscape is highly sensitive to environmental exposures<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. DNA methylation is one of the most widely studied epigenetic modifications in which a methyl group is added to a cytosine residue, most commonly in the context of cytosine-guanine dinucleotides (CpG). Children exposed to severe adversity show DNA methylation changes in genes involved in the vulnerability to stress, neurotransmission, inflammatory responses and behavior<sup><xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR10">10</xref></sup>. Negative childhood exposures can trigger DNA methylation changes in genes that modulate anxiety and related phenotypes, such as the oxytocin receptor, glucocorticoid receptor, serotonin transporter gene, brain-derived neurotrophic factor and glutamate receptor<sup><xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR15">15</xref></sup>. Early-life maternal and paternal stressors are predictive of DNA methylation changes detected in adolescents<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> and both ACEs and DNA methylation changes at the glucocorticoid receptor gene have been associated with increased risk of psychopathologies during adolescence<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Moreover, adverse experiences have been associated to an accelerated biological aging<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. The deviation between the DNA methylation age and the chronological age is a measure of the epigenetic aging rate<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. In children, the Pediatric-Buccal-Epigenetic (PedBE) clock is a tool to measure the biological age, providing an understanding of the environmental exposures that might influence child health and disease<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Recent findings show that psychologically adverse or violent home environments can accelerate epigenetic aging in youth<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Similarly, neighborhood violence or elevated parental depressive symptoms have been associated with both emotional distress and accelerated epigenetic aging in children<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR25">25</xref></sup>. Importantly, an accelerated rate of epigenetic aging predicts the risk of many chronic conditions such as obesity, cancer, Alzheimer's disease, cardiovascular disease, and all-cause mortality risk<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>.</p>
              <p id="Par4">Recent research shows that positive childhood experiences predict positive outcomes in long-term health and can also neutralize the negative impact of ACEs on adult health<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. In this context, interventions to increase awareness and understanding of childhood adversities and to promote family connection have been proposed as strategies to influence health and well-being later in life<sup><xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref></sup>. In addition, multimodal programs that combine several approaches such as cognitive behavioral therapy, exercise, yoga, music, art, EMDR (Eye Movement Desensitization and Reprocessing) therapy, individual counselling and interactions with animals have been proposed to improve wellbeing and mental health in child victims of multiple ACEs<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. Notably, in rodents, an enriched environmental model, which includes cognitive, somatosensorial, motor and visual stimulation, reduces the negative psychological and behavioral consequences of early adversity by modulating trauma-related epigenetic marks and improving neurogenesis and synaptic plasticity<sup><xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref></sup>.</p>
              <p id="Par5">We recently described the protocol and mental health impact of a 1-week multimodal intervention group (n = 44 girls) program for adolescents (aged 13–16 years) reporting 4 or more ACEs<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. After completing the program, the intervention group showed significant reduction in trauma-related outcomes (− 73% in the Short PTSD Rating Interview (SPRINT) scale; − 26% in the Child PTSD Symptom Scale (CPSS)) and a 57% improvement in attention/awareness-related outcomes Mindful Attention Awareness Scale-Adolescents (MAAS-A). This program addresses trauma through evidence-based therapeutic approaches, in an enriched environment that provides social, somatosensory and cognitive stimulation. Based on the literature discussed above, we hypothesize that these conditions may trigger DNA methylation changes in genes involved in the pathophysiology of multiple ACEs, such as vulnerability to stress, neurotransmission, inflammatory responses, behavior and cell aging. We hypothesize that some of the DNA methylation changes may correlate with the mental health improvements that we have previously reported in the same sample<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, providing insights for future mechanistic research. To start testing this hypothesis, we profiled genome-wide DNA methylation levels in saliva samples from control and intervention group participants, at baseline (T1) and post-intervention (T2), in order to detect potential physiologically relevant DNA methylation changes.</p>
            </sec>
            <sec id="Sec2">
              <title>Results</title>
              <sec id="Sec3">
                <title>Intensive multimodal 1-week group program causes genome-wide alterations in DNA methylation</title>
                <p id="Par6">To identify the impact of the intervention on DNA methylation levels at each CpG on the Human MethylationEPIC array (<italic>N</italic> =  &gt; 850,000 sites), we used an ANCOVA model adjusting for DNA methylation level at baseline (T1), BMI, age, ACEs score and cell type proportions (see details in “<xref rid="Sec13" ref-type="sec">Methods</xref>”). This approach revealed that 49 DML exhibited a <italic>p</italic> value &lt; 0.001 and a change in DNA methylation level greater than 10% (Table <xref rid="Tab1" ref-type="table">1</xref>), while 195 DML showed a <italic>p</italic> value &lt; 0.001 and a change in DNA methylation level greater than 5% (Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Intervention-sensitive differentially methylated loci (DML) with p-value lower than 0.001 and a DNA mean difference (T2–T1) of 10% or more (n = 49).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">CpG ID</th><th align="left">Chromosome</th><th align="left">Position</th><th align="left">Strand</th><th align="left">Relative to island position</th><th align="left">FDR</th><th align="left"><italic>P</italic> value</th><th align="left">Mean difference (t2−t1)</th><th align="left">UCSC reference gene symbol</th><th align="left">UCSC reference gene name</th><th align="left">UCSC reference gene group</th><th align="left">UniProt function</th></tr></thead><tbody><tr><td align="left">cg18252633</td><td align="left">chr11</td><td align="left">73054401</td><td align="left">–</td><td align="left">S_Shore</td><td char="." align="char">0.41</td><td align="left">8.25E−07</td><td align="left">− 0.10</td><td align="left"><italic>ARHGEF17</italic></td><td align="left">Rho guanine nucleotide exchange factor 17</td><td align="left">Body</td><td align="left">Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPases, involved in actine cytoskeleton organization</td></tr><tr><td align="left">cg11761483</td><td align="left">chr17</td><td align="left">70723386</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.65</td><td align="left">5.85E−06</td><td align="left">0.15</td><td align="left"><italic>SLC39A11</italic></td><td align="left">Solute carrier family 39 member 11</td><td align="left">Body</td><td align="left">Functions as a zinc ion transmembrane transporter</td></tr><tr><td align="left">cg11377646</td><td align="left">chr1</td><td align="left">11455041</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.69</td><td align="left">1.45E−05</td><td align="left">0.11</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg00537196</td><td align="left">chr14</td><td align="left">52688271</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.49</td><td align="left">2.67E−05</td><td align="left">0.14</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg16270222</td><td align="left">chr17</td><td align="left">41446396</td><td align="left">–</td><td align="left">Island</td><td char="." align="char">0.65</td><td align="left">5.03E−05</td><td align="left">0.10</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg08827579</td><td align="left">chr9</td><td align="left">117150458</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.69</td><td align="left">5.20E−05</td><td align="left">0.15</td><td align="left"><italic>AKNA</italic></td><td align="left">AT-Hook transcription factor</td><td align="left">5'UTR</td><td align="left">Centrosomal protein that plays a key role in cell delamination by regulating microtubule organization; involved in regulation of transcription and inflammatory responses</td></tr><tr><td align="left">cg05105832</td><td align="left">chr10</td><td align="left">64520254</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.66</td><td align="left">5.57E−05</td><td align="left">0.13</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg21052873</td><td align="left">chr12</td><td align="left">124938573</td><td align="left"> + </td><td align="left">N_Shelf</td><td char="." align="char">0.76</td><td align="left">7.37E−05</td><td align="left">0.10</td><td align="left"><italic>NCOR2</italic></td><td align="left">Nuclear receptor corepressor 2</td><td align="left">Body</td><td align="left">Transcriptional corepressor, involved in the regulation of several siglnaling pathways such as Notch</td></tr><tr><td align="left">cg20497635</td><td align="left">chr17</td><td align="left">998504</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.76</td><td align="left">1.14E−04</td><td align="left">0.17</td><td align="left"><italic>ABR</italic></td><td align="left">Active BCR-related gene</td><td align="left">Body</td><td align="left">Functions as an important regulator of RAC1 activity in neurons and macrophages (regulating synaptic transmission, and GTPase mediated signal transduction)</td></tr><tr><td align="left">cg02202133</td><td align="left">chr9</td><td align="left">126312322</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.76</td><td align="left">1.20E−04</td><td align="left">− 0.12</td><td align="left"><italic>DENND1A</italic></td><td align="left">DENN domain containing 1A</td><td align="left">Body</td><td align="left">Guanine nucleotide exchange factor (GEF) that regulates clathrin-mediated endocytosis of synaptic vesicles and mediates exit from early endosomes</td></tr><tr><td align="left">cg16306870</td><td align="left">chr3</td><td align="left">194868790</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">1.93E−04</td><td align="left">0.18</td><td align="left"><italic>XXYLT1; C3orf21</italic></td><td align="left">Xyloside xylosyltransferase 1</td><td align="left">Body</td><td align="left">Glycosyltransferase targetting Notch proteins and coagulation factors, among others</td></tr><tr><td align="left">cg03208742</td><td align="left">chr12</td><td align="left">124475432</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.69</td><td align="left">1.95E−04</td><td align="left">− 0.10</td><td align="left"><italic>ZNF664;ZNF664-FAM101A</italic></td><td align="left">Zinc finger protein 664</td><td align="left">5'UTR</td><td align="left">Zing finger protein involved in transcriptional regulation</td></tr><tr><td align="left">cg25735425</td><td align="left">chr17</td><td align="left">40307262</td><td align="left">–</td><td align="left">Island</td><td char="." align="char">0.79</td><td align="left">2.32E−04</td><td align="left">0.11</td><td align="left"><italic>RAB5C</italic></td><td align="left">Ras-related protein Rab-5C</td><td align="left">TSS1500</td><td align="left">GTP-binding protein involved in protein transport and vesicular traffic</td></tr><tr><td align="left">cg17418085</td><td align="left">chr1</td><td align="left">31229122</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">2.36E−04</td><td align="left">0.15</td><td align="left"><italic>LAPTM5</italic></td><td align="left">Lysosomal-associated transmembrane protein 5</td><td align="left">Body</td><td align="left">Transmembrane receptor associated with lysosomes; involved in embryogenesis and in adult hematopoiesis</td></tr><tr><td align="left">cg01569346</td><td align="left">chr6</td><td align="left">32064148</td><td align="left"> + </td><td align="left">Island</td><td char="." align="char">0.80</td><td align="left">3.42E−04</td><td align="left">− 0.19</td><td align="left"><italic>TNXB</italic></td><td align="left">Tenascin-X</td><td align="left">Body</td><td align="left">Involved in cell adhesion, mediates interactions between cells and the extracellular matrix</td></tr><tr><td align="left">cg07069368</td><td align="left">chr6</td><td align="left">45294931</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.65</td><td align="left">3.44E−04</td><td align="left">0.20</td><td align="left"><italic>RUNX2;SUPT3H</italic></td><td align="left">Runt-related transcription factor 2</td><td align="left">TSS1500;5'UTR;Body</td><td align="left">Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis</td></tr><tr><td align="left">cg05884705</td><td align="left">chr15</td><td align="left">40600099</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">3.52E−04</td><td align="left">0.17</td><td align="left"><italic>PLCB2</italic></td><td align="left">Phospholipase C Beta 2</td><td align="left">1stExon;5'UTR</td><td align="left">Phosphodiesterase involved in lipid metabolism and signal transduction</td></tr><tr><td align="left">cg21005774</td><td align="left">chr14</td><td align="left">22917452</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">3.78E−04</td><td align="left">0.18</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg16002891</td><td align="left">chr12</td><td align="left">6753017</td><td align="left"> + </td><td align="left">N_Shelf</td><td char="." align="char">0.80</td><td align="left">4.23E−04</td><td align="left">0.16</td><td align="left"><italic>ACRBP</italic></td><td align="left">Acrosin-binding protein</td><td align="left">Body</td><td align="left">Acrosomal protein involved in the acrosome formation</td></tr><tr><td align="left">cg24365795</td><td align="left">chr16</td><td align="left">28506015</td><td align="left">–</td><td align="left">N_Shelf</td><td char="." align="char">0.79</td><td align="left">4.45E−04</td><td align="left">0.16</td><td align="left"><italic>APOBR</italic></td><td align="left">Apolipoprotein B receptor</td><td align="left">1stExon</td><td align="left">Macrophage receptor involved in cholesterol and triglycerides metabolism, and lipid transport</td></tr><tr><td align="left">cg10373891</td><td align="left">chr13</td><td align="left">52338758</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">4.88E−04</td><td align="left">0.11</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg25946790</td><td align="left">chr14</td><td align="left">90187489</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">4.91E−04</td><td align="left">0.12</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg01210113</td><td align="left">chr16</td><td align="left">11352835</td><td align="left">–</td><td align="left">S_Shelf</td><td char="." align="char">0.79</td><td align="left">4.91E−04</td><td align="left">0.11</td><td align="left"><italic>–</italic></td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg15210829</td><td align="left">chr17</td><td align="left">2295425</td><td align="left"> + </td><td align="left">N_Shore</td><td char="." align="char">0.79</td><td align="left">5.01E−04</td><td align="left">0.17</td><td align="left"><italic>MNT</italic></td><td align="left">Max-binding protein MNT</td><td align="left">Body</td><td align="left">Binds DNA as a heterodimer with MAX and represses transcription</td></tr><tr><td align="left">cg14909856</td><td align="left">chr9</td><td align="left">117150236</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">5.20E−04</td><td align="left">0.19</td><td align="left"><italic>AKNA</italic></td><td align="left">Microtubule organization protein AKNA</td><td align="left">5'UTR</td><td align="left">Centrosomal protein that plays a key role in cell delamination by regulating microtubule organization; involved in regulation of transcription and inflammatory responses</td></tr><tr><td align="left">cg16959766</td><td align="left">chr7</td><td align="left">36230458</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">5.21E−04</td><td align="left">0.10</td><td align="left"><italic>EEPD1</italic></td><td align="left">Endonuclease/exonuclease/phosphatase family domain-containing protein 1</td><td align="left">Body</td><td align="left">Regulates gene expression linked to cholesterol transport and efflux</td></tr><tr><td align="left">cg22461919</td><td align="left">chr16</td><td align="left">71843295</td><td align="left">–</td><td align="left">S_Shore</td><td char="." align="char">0.76</td><td align="left">5.30E−04</td><td align="left">0.13</td><td align="left"><italic>AP1G1</italic></td><td align="left">AP-1 complex subunit gamma-1</td><td align="left">TSS1500</td><td align="left">Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes</td></tr><tr><td align="left">cg06536724</td><td align="left">chr17</td><td align="left">64544418</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">5.31E−04</td><td align="left">0.16</td><td align="left"><italic>PRKCA</italic></td><td align="left">Protein kinase C alpha type</td><td align="left">Body</td><td align="left">Calcium-activated serine/threonine-protein kinase involved in apoptosis, cell adhesion, angiogenesis, platelet function and inflammation</td></tr><tr><td align="left">cg18169886</td><td align="left">chr2</td><td align="left">25517869</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">5.40E−04</td><td align="left">0.16</td><td align="left"><italic>DNMT3A</italic></td><td align="left">DNA (cytosine-5)-methyltransferase 3A</td><td align="left">Body</td><td align="left">Required for genome-wide de novo methylation and for the establishment of DNA methylation patterns during development</td></tr><tr><td align="left">cg24498454</td><td align="left">chr19</td><td align="left">48673965</td><td align="left">–</td><td align="left">S_Shore</td><td char="." align="char">0.79</td><td align="left">5.43E−04</td><td align="left">0.13</td><td align="left"><italic>LIG1;C19orf68</italic></td><td align="left">Leucine-rich repeats and immunoglobulin-like domains protein 1</td><td align="left">TSS200;1stExon;5'UTR</td><td align="left">Feedback negative regulator of signaling by receptor tyrosine kinases</td></tr><tr><td align="left">cg19913426</td><td align="left">chr17</td><td align="left">55213600</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.76</td><td align="left">5.61E−04</td><td align="left">0.17</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg06066908</td><td align="left">chr6</td><td align="left">138044052</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">5.90E−04</td><td align="left">0.15</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg18700133</td><td align="left">chr17</td><td align="left">8013202</td><td align="left">–</td><td align="left">Island</td><td char="." align="char">0.77</td><td align="left">6.02E−04</td><td align="left">− 0.18</td><td align="left">ALOXE3</td><td align="left">Hydroperoxide isomerase ALOXE3</td><td align="left">Body</td><td align="left">Lipoxygenase involved in lipid metabolism (hydroperoxy eicosatetraenoic acid biosynthesis and sphingolipid metabolism)</td></tr><tr><td align="left">cg20055664</td><td align="left">chr8</td><td align="left">134216562</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">6.37E−04</td><td align="left">− 0.10</td><td align="left">WISP1</td><td align="left">WNT1-inducible-signaling pathway protein 1</td><td align="left">Body</td><td align="left">Downstream regulator in the Wnt/Frizzled-signaling pathway, associated with cell survival</td></tr><tr><td align="left">cg07922719</td><td align="left">chr9</td><td align="left">117150338</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.78</td><td align="left">6.55E−04</td><td align="left">0.15</td><td align="left">AKNA</td><td align="left">AT-Hook transcription factor</td><td align="left">5'UTR</td><td align="left">Centrosomal protein that plays a key role in cell delamination by regulating microtubule organization; involved in regulation of transcription and inflammatory responses</td></tr><tr><td align="left">cg26091486</td><td align="left">chr20</td><td align="left">2687292</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.80</td><td align="left">6.55E−04</td><td align="left">0.12</td><td align="left">EBF4</td><td align="left">EBF family member 4</td><td align="left">Body</td><td align="left">Transcriptional factor which recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3'</td></tr><tr><td align="left">cg26813601</td><td align="left">chr15</td><td align="left">91105486</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">7.23E−04</td><td align="left">0.18</td><td align="left">CRTC3</td><td align="left">CREB-regulated transcription coactivator 3</td><td align="left">Body</td><td align="left">Transcriptional coactivator for CREB1 involved in mitochondrial biogenesis, macrophage activation, lipid catabolism, etc</td></tr><tr><td align="left">cg16815249</td><td align="left">chr6</td><td align="left">111441357</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">7.46E−04</td><td align="left">0.11</td><td align="left">SLC16A10</td><td align="left">Solute carrier family 16 member 10</td><td align="left">Body</td><td align="left">Sodium-independent transporter that mediates the uptake of aromatic acids (involved in thiroid hormone metabolism)</td></tr><tr><td align="left">cg08609270</td><td align="left">chrX</td><td align="left">144903125</td><td align="left"> + </td><td align="left">Island</td><td char="." align="char">0.76</td><td align="left">7.94E−04</td><td align="left">− 0.12</td><td align="left">SLITRK2</td><td align="left">SLIT and NTRK like family member 2</td><td align="left">1stExon; 5'UTR</td><td align="left">Protein involved in synaptogenesis that promotes excitatory synapse differentiation</td></tr><tr><td align="left">cg12078157</td><td align="left">chr6</td><td align="left">13612218</td><td align="left">–</td><td align="left">N_Shelf</td><td char="." align="char">0.69</td><td align="left">7.95E−04</td><td align="left">0.13</td><td align="left">SIRT5</td><td align="left">Sirtuin 5</td><td align="left">3'UTR</td><td align="left">Mitochondrial NAD-dependent deacylase involved in mitochondrion organization, reactive oxygen species metabolism, etc</td></tr><tr><td align="left">cg26360755</td><td align="left">chr19</td><td align="left">51539314</td><td align="left"> + </td><td align="left">S_Shelf</td><td char="." align="char">0.80</td><td align="left">8.02E−04</td><td align="left">0.10</td><td align="left">KLK12</td><td align="left">Kallikrein-12</td><td align="left">TSS1500</td><td align="left">Protein with peptidase activity</td></tr><tr><td align="left">cg11913565</td><td align="left">chr9</td><td align="left">137814810</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.80</td><td align="left">8.07E−04</td><td align="left">0.16</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg05968174</td><td align="left">chrX</td><td align="left">24187388</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.78</td><td align="left">8.61E−04</td><td align="left">0.15</td><td align="left">ZFX</td><td align="left">Zinc finger X-chromosomal protein</td><td align="left">5'UTR</td><td align="left">Probable transcriptional activator</td></tr><tr><td align="left">cg21110034</td><td align="left">chr5</td><td align="left">130752683</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">8.71E−04</td><td align="left">0.17</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg25550677</td><td align="left">chr6</td><td align="left">43027568</td><td align="left"> + </td><td align="left">Island</td><td char="." align="char">0.80</td><td align="left">8.91E−04</td><td align="left">0.14</td><td align="left">KLC4;MRPL2</td><td align="left">Kinesin light chain 4</td><td align="left">TSS1500;5'UTR;TSS200</td><td align="left">Microtubule-associated force-producing protein that plays a role in organelle transport</td></tr><tr><td align="left">cg22348534</td><td align="left">chr8</td><td align="left">37887424</td><td align="left"> + </td><td align="left">N_Shore</td><td char="." align="char">0.79</td><td align="left">9.10E−04</td><td align="left">0.16</td><td align="left">EIF4EBP1</td><td align="left">Eukaryotic translation initiation factor 4E-binding protein 1</td><td align="left">TSS1500</td><td align="left">Repressor of translation initiation that regulates EIF4E activity; regulates protein translation by hormones, growth factors and other stimuli that signal through the MAP kinase and mTORC1 pathways</td></tr><tr><td align="left">cg13544012</td><td align="left">chr9</td><td align="left">135709670</td><td align="left">–</td><td align="left">OpenSea</td><td char="." align="char">0.80</td><td align="left">9.10E−04</td><td align="left">0.11</td><td align="left">C9orf98</td><td align="left">Adenylate kinase 8</td><td align="left">Body</td><td align="left">Nucleoside monophosphate (NMP) kinase that catalyzes the reversible transfer of the terminal phosphate group between nucleoside triphosphates and monophosphates</td></tr><tr><td align="left">cg13356427</td><td align="left">chr1</td><td align="left">6520354</td><td align="left"> + </td><td align="left">N_Shore</td><td char="." align="char">0.79</td><td align="left">9.26E−04</td><td align="left">0.14</td><td align="left">ESPN</td><td align="left">Espin</td><td align="left">3'UTR</td><td align="left">Multifunctional actin-bundling protein</td></tr><tr><td align="left">cg01515803</td><td align="left">chr13</td><td align="left">51289817</td><td align="left"> + </td><td align="left">OpenSea</td><td char="." align="char">0.79</td><td align="left">9.50E−04</td><td align="left">0.15</td><td align="left">DLEU7</td><td align="left">Leukemia-associated protein 7</td><td align="left">Body</td><td align="left">Protein coding gene deleted In Lymphocytic Leukemia 7</td></tr></tbody></table><table-wrap-foot><p>Function of the associated gene is reported as in UniProt database.</p></table-wrap-foot></table-wrap></p>
                <p id="Par7">Out of the 49 DML, 87% showed an increase in DNA methylation level from baseline to post-treatment and 37 DML reside in known genes. These 49 DML were distributed across all human chromosomes except the Y chromosome (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a) and were most often found within gene bodies (57%), followed by 5′ untranslated regions (27%), and gene promoter regions of genes (up to 1500 basepairs upstream of the gene transcription start site) (16%) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). Most of the DML were in open sea regions (more than 4 kb from a CpG island) (64%) and 12% were located within CpG islands (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c). Considering the probe locations included on the array, the genomic region and location enrichments of the DML were not significant (<italic>p</italic> value &gt; 0.05).<fig id="Fig1"><label>Figure 1</label><caption><p>(<bold>a</bold>) Manhattan plot of intervention-sensitive differentially methylated loci (DML). The X-axis represents the chromosomal position and the Y-axis represents the significance on a − log 10 scale. The red and dashed line indicates the threshold for the cut-off p value &lt; 0.001 and DNA methylation mean difference (T2−T1) of 10% or more; (<bold>b</bold>) Percent distribution to standard genomic features of DML with available information (n = 37). 5′UTR = 5′ untranslated region’ 3′UTR = 3′ untranslated region; TSS = transcription start site; TSS200 = 0–200 bp upstream of TSS; 44 TSS1500 = 200–1500 bp upstream of TSS to standard genomic features; (<bold>c</bold>) Percent distribution of intervention-sensitive DML (n = 49) to island relative positions. Shores are considered regions more than 4 kb from CpG islands, shelves are regions 2–4 kb from CpG islands, and other/open sea regions are isolated CpG sites in the genome that do not have a specific designation.</p></caption><graphic xlink:href="41598_2022_21246_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
              <sec id="Sec4">
                <title>Functional roles of intervention-sensitive DML</title>
                <p id="Par8">Using a meta-database restricted to the 49 DMLs to identify molecular interactions for network biology (ConsensusPathDB-human tool), we conducted a pathway analysis and found a significant enrichment of functional interactions associated with the nervous, endocrine, immune systems, and processes involved in cancer, diabetes and cardiovascular disease (top 20 pathways with FDR q-value &lt; 0.03, Table <xref rid="Tab2" ref-type="table">2</xref>; all pathways with FDR q-value ≤ 0.05, Supplementary Table <xref rid="MOESM1" ref-type="media">S2</xref>). These findings support links to neurophysiological processes affected by childhood adversity<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Top 20 functional interactions of the 49 meditation-sensitive DML (<italic>p</italic> value &lt; 0.001 and mean difference (T2−T1) &gt; 10%) using the ConsensusPath tool.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Consensus Path name</th><th align="left">Functional set id</th><th align="left"><italic>p</italic> value</th><th align="left">FDR q-value</th></tr></thead><tbody><tr><td align="left">Acetylcholine regulates insulin secretion (Reactome)</td><td align="left">118332</td><td char="." align="char">0.0002</td><td char="." align="char">0.023</td></tr><tr><td align="left">Hematopoietic stem cell gene regulation by GABP alpha–beta complex (Wikipathways)</td><td align="left">3874547</td><td char="." align="char">0.0007</td><td char="." align="char">0.023</td></tr><tr><td align="left">Amoebiasis—Homo sapiens (human) (KEGG)</td><td align="left">167455</td><td char="." align="char">0.0010</td><td char="." align="char">0.023</td></tr><tr><td align="left">Regulation of eif-4e and p70s6 kinase (BioCarta)</td><td align="left">282015</td><td char="." align="char">0.0012</td><td char="." align="char">0.023</td></tr><tr><td align="left">Parathyroid hormone synthesis secretion and action—Homo sapiens (human) (KEGG)</td><td align="left">167307</td><td char="." align="char">0.0013</td><td char="." align="char">0.023</td></tr><tr><td align="left">Follicle Stimulating Hormone (FSH) signaling pathway (Wikipathways)</td><td align="left">3874074</td><td char="." align="char">0.0014</td><td char="." align="char">0.023</td></tr><tr><td align="left">IL8- and CXCR1-mediated signaling events (PID)</td><td align="left">264396</td><td char="." align="char">0.0015</td><td char="." align="char">0.023</td></tr><tr><td align="left">GPCR GroupI metabotropic glutamate receptor (INOH)</td><td align="left">299561</td><td char="." align="char">0.0015</td><td char="." align="char">0.023</td></tr><tr><td align="left">Thyroid hormone signaling pathway—Homo sapiens (human) (KEGG)</td><td align="left">167527</td><td char="." align="char">0.0017</td><td char="." align="char">0.023</td></tr><tr><td align="left">Retinoic acid receptors-mediated signaling (PID)</td><td align="left">264415</td><td char="." align="char">0.0017</td><td char="." align="char">0.023</td></tr><tr><td align="left">Alpha 6 Beta 4 signaling pathway (Wikipathways)</td><td align="left">3874238</td><td char="." align="char">0.0021</td><td char="." align="char">0.024</td></tr><tr><td align="left">IL8- and CXCR2-mediated signaling events (PID)</td><td align="left">264520</td><td char="." align="char">0.0022</td><td char="." align="char">0.024</td></tr><tr><td align="left">African trypanosomiasis—Homo sapiens (human) (KEGG)</td><td align="left">167452</td><td char="." align="char">0.0024</td><td char="." align="char">0.024</td></tr><tr><td align="left">Target Of rapamycin (TOR) signaling (Wikipathways)</td><td align="left">3873991</td><td char="." align="char">0.0025</td><td char="." align="char">0.024</td></tr><tr><td align="left">PAR1-mediated thrombin signaling events (PID)</td><td align="left">264368</td><td char="." align="char">0.0037</td><td char="." align="char">0.028</td></tr><tr><td align="left">PLC beta mediated events (Reactome)</td><td align="left">46932</td><td char="." align="char">0.0037</td><td char="." align="char">0.028</td></tr><tr><td align="left">G-protein mediated events (Reactome)</td><td align="left">46967</td><td char="." align="char">0.0039</td><td char="." align="char">0.028</td></tr><tr><td align="left">Proton pump inhibitor pathway pharmacodynamics (PharmGKB)</td><td align="left">3193117</td><td char="." align="char">0.0040</td><td char="." align="char">0.028</td></tr><tr><td align="left">Endocrine and other factor-regulated calcium reabsorption—Homo sapiens (human) (KEGG)</td><td align="left">167435</td><td char="." align="char">0.0042</td><td char="." align="char">0.028</td></tr><tr><td align="left">Regulation of RhoA activity (PID)</td><td align="left">264551</td><td char="." align="char">0.0044</td><td char="." align="char">0.028</td></tr></tbody></table></table-wrap></p>
                <p id="Par9">Sequence motif enrichments to identify transcription factors binding sites among the 49 intervention-sensitive DMLs revealed 21 significantly enriched motifs (E-value &lt; 0.05, Table <xref rid="Tab3" ref-type="table">3</xref>). The top 5 sequence motifs corresponded to binding sites for ETV4, ZN341, ETV2, SP1, and BC11A transcription factors, which are involved in cell differentiation, regulation of immune homeostasis, blood cell differentiation, immune responses, cancer, cardiovascular disease, diabetes and brain development, respectively, among other biological processes (UniProt database).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Transcription factor motif enrichment analysis of intervention-sensitive DML.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Rank</th><th align="left">Transcription factor</th><th align="left">Adj. <italic>P</italic> value (FDR)</th><th align="left"><italic>E</italic> value</th><th align="left">No of DML</th><th align="left">UCSC reference gene name</th><th align="left">UniProt function</th></tr></thead><tbody><tr><td align="left">1</td><td align="left"><italic>ETV4</italic></td><td align="left">1.56E−08</td><td align="left">6.24E−06</td><td char="." align="char">22</td><td align="left">ETS translocation variant 4</td><td align="left">Transcriptional activator involved in cell differentiation</td></tr><tr><td align="left">2</td><td align="left"><italic>ZN341</italic></td><td align="left">2.10E−07</td><td align="left">8.41E−05</td><td char="." align="char">21</td><td align="left">Zinc finger protein 341</td><td align="left">Transcriptional activator of STAT3 involved in the regulation of immune homeostasis</td></tr><tr><td align="left">3</td><td align="left"><italic>ETV2</italic></td><td align="left">3.85E−07</td><td align="left">1.54E−04</td><td char="." align="char">26</td><td align="left">ETS translocation variant 2</td><td align="left">Transcriptional activator involved in blood cells differentiation, Notch and Wnt signalling pathways</td></tr><tr><td align="left">4</td><td align="left"><italic>SP1</italic></td><td align="left">1.63E−06</td><td align="left">6.53E−04</td><td char="." align="char">8</td><td align="left">Transcription factor Sp1</td><td align="left">Transcritional factor that regulates the expression of genes involved in cell growth, apoptosis, angiogenesis, differentiation and immune responses</td></tr><tr><td align="left">5</td><td align="left"><italic>BC11A</italic></td><td align="left">2.48E−06</td><td align="left">9.96E−04</td><td char="." align="char">25</td><td align="left">B-cell lymphoma/leukemia 11A</td><td align="left">Transcription factor involved in brain development, hematopoiesis, lymphopoiesis</td></tr><tr><td align="left">6</td><td align="left"><italic>ERG</italic></td><td align="left">2.97E−06</td><td align="left">1.19E−03</td><td char="." align="char">25</td><td align="left">ETS Transcription Factor ERG</td><td align="left">Transcriptional regulator involved in cell differentiation</td></tr><tr><td align="left">7</td><td align="left"><italic>SPI1</italic></td><td align="left">3.39E−06</td><td align="left">1.36E−03</td><td char="." align="char">16</td><td align="left">Transcription factor PU.1</td><td align="left">Transcriptional activator involved in the differentiation or activation of macrophages or B-cells</td></tr><tr><td align="left">8</td><td align="left"><italic>IRF2</italic></td><td align="left">5.87E−06</td><td align="left">2.35E−03</td><td char="." align="char">12</td><td align="left">Interferon regulatory factor 2</td><td align="left">Transcriptional activator involved in immune response</td></tr><tr><td align="left">9</td><td align="left"><italic>ELF3</italic></td><td align="left">7.34E−06</td><td align="left">2.94E−03</td><td char="." align="char">22</td><td align="left">ETS-related transcription factor Elf-3</td><td align="left">Transcriptional factor involved in cell differentiation, extracellular matric organization and inflammatory response</td></tr><tr><td align="left">10</td><td align="left"><italic>SP3</italic></td><td align="left">8.08E−06</td><td align="left">3.24E−03</td><td char="." align="char">16</td><td align="left">Transcription factor Sp3</td><td align="left">Transcritional activator of genes involved in cell-cycle regulation, hormone-induction and house-keeping</td></tr><tr><td align="left">11</td><td align="left"><italic>ETV5</italic></td><td align="left">8.14E−06</td><td align="left">3.27E−03</td><td char="." align="char">37</td><td align="left">ETS translocation variant 5</td><td align="left">Transcription factor involved in cell differentiation and cellular response to oxidative stress</td></tr><tr><td align="left">12</td><td align="left"><italic>IRF8</italic></td><td align="left">1.45E−05</td><td align="left">5.83E−03</td><td char="." align="char">19</td><td align="left">Interferon regulatory factor 8</td><td align="left">Transcription negative regulator in cells of the immune system, involved in the immune response</td></tr><tr><td align="left">13</td><td align="left"><italic>KLF15</italic></td><td align="left">1.48E−05</td><td align="left">5.94E−03</td><td char="." align="char">15</td><td align="left">Krueppel-like factor 15</td><td align="left">Transcription factor involved in many processes such as glucose homeostasis, insulin response, Wnt signalling pathway</td></tr><tr><td align="left">14</td><td align="left"><italic>VEZF1</italic></td><td align="left">2.69E−05</td><td align="left">1.08E−02</td><td char="." align="char">23</td><td align="left">Vascular endothelial zinc finger 1</td><td align="left">Transcription factor involved in cellular defense response and angiogenesis</td></tr><tr><td align="left">15</td><td align="left"><italic>E2F7</italic></td><td align="left">3.69E−05</td><td align="left">1.48E−02</td><td char="." align="char">17</td><td align="left">Transcription factor E2F7</td><td align="left">Atypical E2F transcription factor that participates in various processes such as angiogenesis, polyploidization of specialized cells and DNA damage response</td></tr><tr><td align="left">16</td><td align="left"><italic>SP4</italic></td><td align="left">5.12E−05</td><td align="left">2.05E−02</td><td char="." align="char">20</td><td align="left">Transcription factor Sp4</td><td align="left">Transcriptional activator</td></tr><tr><td align="left">17</td><td align="left"><italic>SPIB</italic></td><td align="left">5.86E−05</td><td align="left">2.35E−02</td><td char="." align="char">11</td><td align="left">Transcription factor Spi-B</td><td align="left">Transcriptional activator involved in cell differentiation that can act as a lymphoid-specific enhancer</td></tr><tr><td align="left">18</td><td align="left"><italic>IRF1</italic></td><td align="left">6.05E−05</td><td align="left">2.43E−02</td><td char="." align="char">10</td><td align="left">Interferon regulatory factor 1</td><td align="left">Transcriptional regulator involved in immune response and apoptosis</td></tr><tr><td align="left">19</td><td align="left"><italic>EHF</italic></td><td align="left">7.73E−05</td><td align="left">3.10E-02</td><td char="." align="char">22</td><td align="left">ETS homologous factor</td><td align="left">Transcriptional activator involved in regulating epithelial cell differentiation and proliferation</td></tr><tr><td align="left">20</td><td align="left"><italic>ZN770</italic></td><td align="left">8.21E−05</td><td align="left">3.29E-02</td><td char="." align="char">21</td><td align="left">Zinc finger protein 770</td><td align="left">Transcription regulator</td></tr><tr><td align="left">21</td><td align="left"><italic>ELF5</italic></td><td align="left">1.04E−04</td><td align="left">4.16E-02</td><td char="." align="char">21</td><td align="left">ETS-related transcription factor Elf-5</td><td align="left">Transcriptionally activator involved in cell differentiation, that regulates the later stages of keratinocytes terminal differentiation.</td></tr></tbody></table><table-wrap-foot><p>DNA sequences flanking the 49 intervention-sensitive DML (+ /− 250 bp) were used to identify enriched motifs using the AME suite package (<italic>p</italic> value ≤ 0.0001; E-value ≤ 0.05). Transcription factors predicted to bind to each motif, Bonferroni adjusted <italic>p</italic> value, E-value, and the number of DML where the motif is present are shown. Functions of the transcription factors were obtained using the UniProt database.</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec5">
                <title>Impact of multimodal intervention on epigenetic age acceleration</title>
                <p id="Par10">Pearson's correlation analysis revealed no association between baseline Intrinsic Epigenetic Age Acceleration (IEAA) and ACE total score (n = 44; <italic>p</italic> value = 0.43: r = − 0.13). The analyses of the three categories of adversity assessed by the standard ACE questionnaire (i.e. abuse, neglect and household challenges), revealed a weak but significant positive correlation between IEAA and exposure to abuse (emotional, physical and sexual) (<italic>p</italic> value = 0.03: r = 0.33) while neglect (emotional and physical) and household challenges (separation from biological parents, witnessing domestic violence, household substance abuse, mental illness in household and having incarcerated family members) were not associated with epigenetic accelerated aging (neglect: <italic>p</italic> value = 0.07: r = 0.27; household challenges: <italic>p</italic> value = 0.13: r = − 0.23). No significant difference was found in DNA methylation age or Intrinsic Epigenetic Age Acceleration (IEAA) between groups, calculated at T1 and T2 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>; Supplementary Table <xref rid="MOESM1" ref-type="media">S3</xref>a). The intervention did not have any significant impact on the participants’ IEAA according to the ANCOVA model (coefficient = − 0.661, SE = 0.874, <italic>p</italic> value = 0.454) (Supplementary Table <xref rid="MOESM1" ref-type="media">S3</xref>b).<fig id="Fig2"><label>Figure 2</label><caption><p>(<bold>a</bold>) Positive correlation between baseline Intrinsic Epigenetic Age Acceleration (IEAA) and exposure to abuse (<italic>p</italic> value = 0.03: r = 0.33). IEAA positive values indicate that biological age is higher than chronological age, whereas negative values indicate that biological age is lower than chronological age. Abuse score was calculated as the sum of individual scores for emotional, physical and sexual abuse on the 10-item ACE scale. (<bold>b</bold>) IEAA adjusted by cell type proportions in control and intervention groups before and after the program. No effect of the intervention on IEAA was detected (Δ IEAA (T2−T1) control vs intervention group, <italic>p</italic> value = 0.23; Supplementary Table <xref rid="MOESM1" ref-type="media">S2</xref>).</p></caption><graphic xlink:href="41598_2022_21246_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec6">
                <title>Correlation between psychological and DNA methylation outcomes.</title>
                <p id="Par11">Since we previously reported a significant improvement in attention/awareness-related outcomes and a reduction in trauma-related outcomes following the 1-week intervention group program<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, we next sought to identify DNA methylation changes related to psychological outcomes by comparing differences in DNA methylation levels and changes in the scores for Attention Awareness Scale-Adolescents (MAAS-A), trauma (the Short PTSD Rating Interview (SPRINT)), and the Child PTSD Symptom Scale (CPSS)) at baseline (T1) and post-intervention (T2). This approach revealed significant correlations of DNA methylation levels at 274 CpGs with MAAS-A scores (<italic>p</italic> value &lt; 1 × 10<sup>–3</sup>, r &gt; 0.5, Supplementary Table <xref rid="MOESM1" ref-type="media">S4</xref>). However, none of these CpGs corresponded to the intervention-sensitive DML described above and they did not show significant functional enrichment (Supplementary Table <xref rid="MOESM1" ref-type="media">S5</xref>). Improved SPRINT and CPSS scores significantly correlated with DNA methylation levels at 160 and 202 CpGs, respectively (<italic>p</italic> value &lt; 1 × 10<sup>–3</sup>, r &gt; 0.5, Supplementary Tables <xref rid="MOESM1" ref-type="media">S6</xref> and <xref rid="MOESM1" ref-type="media">S7</xref>). Two of these genes corresponded to the intervention-sensitive DMLs described above: <italic>SIRT5</italic> gene (Sirtuin 5; <italic>p</italic> value: 0.0001, r = − 0.59) and <italic>TRAPPC2L</italic> gene (Trafficking Protein Particle Complex Subunit 2L; <italic>p</italic> value: 0.00002, r = − 0.55; Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>. The DNA methylation levels at 35 CpGs correlated with both CPSS and SPRINT scores and Fisher test confirmed that the CpG overlap between scales was significant (<italic>p</italic> value &lt; 1 × 10<sup>–5</sup>). This observation is consistent with the fact that both SPRINT and CPSS scales measure PTSD-related outcomes and that the results from both scales were highly correlated in our previous report (r = 0.833, <italic>p</italic> value &lt; 1 × 10<sup>–3</sup>)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Annotation of these 35 CpGs to genes revealed the known functions of the encoded proteins (Table <xref rid="Tab4" ref-type="table">4</xref>) and an enrichment analysis detected functional interactions involved in metabolic, cardiovascular, immune and neural signaling (<italic>q</italic>-value &lt; 0.04, Supplementary Table <xref rid="MOESM1" ref-type="media">S8</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Function (Uniprot database) of the genes associated to the 35 CpGs found to correlate with both CPSS and SPRINT scales.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">CpG ID</th><th align="left">Chromosome</th><th align="left">Position</th><th align="left">Strand</th><th align="left">Relative to island position</th><th align="left">UCSC reference gene symbol</th><th align="left">UCSC reference gene group</th><th align="left">UCSC reference gene name</th><th align="left">UniProt function</th></tr></thead><tbody><tr><td align="left">cg11029504</td><td align="left">chr9</td><td align="left">80512104</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">GNAQ</td><td align="left">Body</td><td align="left">Guanine nucleotide-binding protein G(q) subunit alpha</td><td align="left">Guanine nucleotide-binding protein involved in transmembrane signaling systems, action potential, glutamate signaling pathway, and other processes, as modulator or transducer</td></tr><tr><td align="left">cg19041132</td><td align="left">chr17</td><td align="left">74380824</td><td align="left">–</td><td align="left">Island</td><td align="left">SPHK1</td><td align="left">5'UTR; 1stExon; TSS1500</td><td align="left">Sphingosine kinase 1</td><td align="left">Protein kinase that catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate, involved in the regulation of inflammatory response and neuroinflammation</td></tr><tr><td align="left">cg07300846</td><td align="left">chr16</td><td align="left">29888571</td><td align="left"> + </td><td align="left">S_Shore</td><td align="left">SEZ6L2</td><td align="left">Body</td><td align="left">Seizure 6-like protein 2</td><td align="left">Protein that contributes to specialized endoplasmic reticulum functions in neurons</td></tr><tr><td align="left">cg22531801</td><td align="left">chr1</td><td align="left">235806070</td><td align="left"> + </td><td align="left">S_Shore</td><td align="left">GNG4</td><td align="left">5'UTR</td><td align="left">Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4</td><td align="left">Guanine nucleotide-binding protein involved in transmembrane signaling systems, severla neurotransmitter signaling pathways, and other processes, as modulator or transducer</td></tr><tr><td align="left">cg10595547</td><td align="left">chr10</td><td align="left">119310911</td><td align="left"> + </td><td align="left">N_Shore</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg11478273</td><td align="left">chr8</td><td align="left">128806682</td><td align="left">–</td><td align="left">Island</td><td align="left">PVT1</td><td align="left">TSS200</td><td align="left">Pvt1 Oncogene</td><td align="left">Long non-coding RNA identified as a candidate oncogene</td></tr><tr><td align="left">cg01759889</td><td align="left">chrX</td><td align="left">68725086</td><td align="left"> + </td><td align="left">Island</td><td align="left">FAM155B</td><td align="left">1stExon; 5'UTR</td><td align="left">Family With Sequence Similarity 155 Member B</td><td align="left">Component of the NALCN channel complex, involved in the regulation of the resting membrane potential and neuronal excitability</td></tr><tr><td align="left">cg25902682</td><td align="left">chr5</td><td align="left">79461463</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">SERINC5</td><td align="left">Body</td><td align="left">Serine incorporator 5</td><td align="left">Enhances the incorporation of serine into phosphatidylserine and sphingolipids, involved in immunity, lipid metabolism and myelin formation</td></tr><tr><td align="left">cg05374956</td><td align="left">chr19</td><td align="left">5838735</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">FUT6</td><td align="left">1stExon; 5'UTR</td><td align="left">4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6</td><td align="left">Glycosyltransferase protein involved in glycosylation and lipid metabolism</td></tr><tr><td align="left">cg00672930</td><td align="left">chr8</td><td align="left">130585711</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">CCDC26</td><td align="left">Body</td><td align="left">Putative coiled-coil domain-containing 26</td><td align="left">Long non-coding RNA identified in myelocyte-monocyte lineage</td></tr><tr><td align="left">cg12153422</td><td align="left">chr14</td><td align="left">75075712</td><td align="left"> + </td><td align="left">N_Shore</td><td align="left">LTBP2</td><td align="left">Body</td><td align="left">Latent-transforming growth factor beta-binding protein 2</td><td align="left">Plays an integral structural role in elastic-fiber architectural organization and/or assembly</td></tr><tr><td align="left">cg05694971</td><td align="left">chr15</td><td align="left">36872036</td><td align="left">–</td><td align="left">S_Shore</td><td align="left">C15orf41</td><td align="left">5'UTR;1stExon</td><td align="left">CDAN1-interacting nuclease 1</td><td align="left">Involved in erythroid cell differentiation</td></tr><tr><td align="left">cg20412539</td><td align="left">chr7</td><td align="left">999153</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg17290488</td><td align="left">chr5</td><td align="left">179281560</td><td align="left">–</td><td align="left">N_Shelf</td><td align="left">C5orf45</td><td align="left">Body</td><td align="left">MRN complex-interacting protein</td><td align="left">Involved in cellular response to DNA damage and the maintenance of genome stability through its association with the MRN damage-sensing complex</td></tr><tr><td align="left">cg13451093</td><td align="left">chr9</td><td align="left">137040612</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg15757326</td><td align="left">chr18</td><td align="left">61704584</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg11856215</td><td align="left">chr11</td><td align="left">63535358</td><td align="left">–</td><td align="left">N_Shore</td><td align="left">C11orf95</td><td align="left">Body</td><td align="left">Zinc finger translocation-associated protein</td><td align="left">Negative regulator of transcription</td></tr><tr><td align="left">cg19816811</td><td align="left">chr7</td><td align="left">27188364</td><td align="left"> + </td><td align="left">N_Shore</td><td align="left">HOXA6</td><td align="left">TSS1500</td><td align="left">Homeobox protein Hox-A6</td><td align="left">Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior–posterior axis</td></tr><tr><td align="left">cg00094518</td><td align="left">chr7</td><td align="left">130418549</td><td align="left"> + </td><td align="left">Island</td><td align="left">KLF14</td><td align="left">1stExon</td><td align="left">Krueppel-like factor 14</td><td align="left">Transcription factor involved in various processes including sphingolipid mediated signaling pathway</td></tr><tr><td align="left">cg27380803</td><td align="left">chr17</td><td align="left">62034801</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">SCN4A</td><td align="left">Body</td><td align="left">Sodium channel protein type 4 subunit alpha</td><td align="left">Subunit of a voltage-gated sodium channel complex, involved in neuronal action potential, muscle contraction, etc</td></tr><tr><td align="left">cg22246918</td><td align="left">chr13</td><td align="left">51094655</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg11336382</td><td align="left">chr1</td><td align="left">228658646</td><td align="left">–</td><td align="left">N_Shore</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg11283677</td><td align="left">chr17</td><td align="left">60727886</td><td align="left">–</td><td align="left">N_Shore</td><td align="left">MRC2</td><td align="left">Body</td><td align="left">C-type mannose receptor 2</td><td align="left">May play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity; involved in collagen catabolism, endocytosis, etc</td></tr><tr><td align="left">cg07401516</td><td align="left">chr5</td><td align="left">95571107</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg24513433</td><td align="left">chr18</td><td align="left">47088234</td><td align="left">–</td><td align="left">Island</td><td align="left">LIPG</td><td align="left">TSS200</td><td align="left">Endothelial lipase</td><td align="left">Exerts both phospholipase and triglyceride lipase activities; involved in lipid metabolism and cell proliferation</td></tr><tr><td align="left">cg20766178</td><td align="left">chrX</td><td align="left">71131060</td><td align="left"> + </td><td align="left">Island</td><td align="left">NHSL2</td><td align="left">1stExon</td><td align="left">NHS-like protein 2</td><td align="left">Protein involed in cell differentiation</td></tr><tr><td align="left">cg07724623</td><td align="left">chr1</td><td align="left">115397409</td><td align="left">–</td><td align="left">N_Shore</td><td align="left">SYCP1</td><td align="left">TSS200</td><td align="left">Synaptonemal complex protein 1</td><td align="left">Major component of the transverse filaments of synaptonemal complexes; involved in cell division</td></tr><tr><td align="left">cg22154449</td><td align="left">chr18</td><td align="left">56930452</td><td align="left"> + </td><td align="left">N_Shore</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg16941643</td><td align="left">chr9</td><td align="left">127277206</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg23341182</td><td align="left">chr10</td><td align="left">102046768</td><td align="left"> + </td><td align="left">S_Shore</td><td align="left">BLOC1S2</td><td align="left">TSS1500</td><td align="left">Biogenesis of lysosome-related organelles complex 1 subunit 2</td><td align="left">Component of the BLOC-1 complex, involved in biogenesis of lysosome-related organelles, axonal transport, neurite extension, neuron differentiation, and othe processes</td></tr><tr><td align="left">cg20655103</td><td align="left">chr8</td><td align="left">143792280</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">LOC100288181</td><td align="left">Body</td><td align="left">LncRNA Associated With Ovarian Cancer 1</td><td align="left">Long non-coding RNA associated with ovarian cancer</td></tr><tr><td align="left">cg19852286</td><td align="left">chr5</td><td align="left">173237320</td><td align="left"> + </td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg06179698</td><td align="left">chr2</td><td align="left">176671985</td><td align="left">–</td><td align="left">OpenSea</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">cg06326092</td><td align="left">chr16</td><td align="left">30034487</td><td align="left">–</td><td align="left">S_Shore</td><td align="left">C16orf92</td><td align="left">TSS200</td><td align="left">Fertilization-influencing membrane protein</td><td align="left">May play a role in sperm-oocyte fusion during fertilization</td></tr><tr><td align="left">cg00454932</td><td align="left">chr1</td><td align="left">171750547</td><td align="left"> + </td><td align="left">Island</td><td align="left">METTL13</td><td align="left">TSS1500</td><td align="left">eEF1A lysine and N-terminal methyltransferase</td><td align="left">Methyltransferase involved in the negative regulation of mRNA translation</td></tr></tbody></table></table-wrap></p>
              </sec>
            </sec>
            <sec id="Sec7">
              <title>Discussion</title>
              <p id="Par12">Here we describe a genome-wide DNA methylation analysis from saliva samples, as an extension of our previous study that showed the mental health benefits of an intensive multimodal 1-week group program involving mindfulness training, artistic expression and EMDR in adolescent girls with a history of 4 or more ACEs (full details on the program protocol and psychological outcomes are described in Roque Lopez et al.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>).</p>
              <p id="Par13">Forty-nine DML were sensitive to the intervention with a methylation change greater than 10% (<italic>p</italic> value &lt; 0.001). Fifty-four percent of these DML were located in the body of genes, of which 76% showed increases in DNA methylation levels post-intervention, which is generally associated with active transcription in proliferative tissues<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
              <p id="Par14">Although DNA methylation analysis from saliva samples might be not representative of other tissue type programming, some reports have shown correlations between DNA methylation levels in brain, blood and saliva<sup><xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR41">41</xref></sup>. A biological pathway-enrichment analysis of the 49 intervention-sensitive DML-associated genes suggests the modulation of several functional processes associated with diseases linked to early childhood adversity, including several biological processes involved in neural signaling and substance abuse disorders (e.g., glutamate receptor, beta agonist/beta blocker, cholinergic, glutamatergic, serotoninergic and dopaminergic synapses and opioid, oxytocin and endocannabinoid signaling, long-term depression and potentiation). These findings are consistent with other reports showing that ACEs can trigger DNA methylation changes in genes that modulate mental health and behavior, such as serotonin transporter and glucocorticoid receptor genes<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>, brain-derived neurotrophic factor<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> and glutamate receptor<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, oxytocin receptor<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. DML-associated genes also were enriched in processes involved in neural signaling and substance abuse disorders (e.g., glutamate receptor, beta agonist/beta blocker, cholinergic, glutamatergic, serotoninergic and dopaminergic synapses and opioid, oxytocin and endocannabinoid signaling, long-term depression and potentiation). In addition, these DML-associated genes were significantly enriched in processes involved in cardiovascular health (e.g., endothelins, vascular smooth muscle contraction, thromboxane A2 receptor and calcium signaling, beta-agonist/beta-blocker pathways), diabetes (e.g., insulin secretion, leptin signaling, pancreatic secretion, AGE-RAGE signaling) and cancer (e.g., choline metabolism, WNT, ErbB and EGF-EGF receptor signaling, cancer-related microRNAs, NOTCH signaling), which are non-communicable diseases more likely to appear in 18 year old adults or older with a history of at least 4 ACEs than in those with none<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Inflammation also has been reported in stress-related disorders<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup> and the enrichment analysis suggests that the intervention may regulate inflammation through the modulation of IL8- and chemokine G-coupled receptor CXCR1- and CXCR2-mediated signaling. Furthermore, stress-related DNA methylation changes were associated with the enrichment in several hormone networks (e.g., follicle stimulating hormone signaling, thyroid hormone synthesis and signaling, androgen receptor signaling, aldosterone synthesis and secretion), which are regulated by hypothalamus-pituitary endocrine axes known to be sensitive to stress and childhood adversity<sup><xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR47">47</xref></sup>. Consistent with these findings, the top 5 significantly enriched DNA sequence motifs corresponding to transcription factors binding sites are involved in the regulation of similar processes. ETV4 and ETV2 are transcription factors of the ETS family that have been largely involved in carcinogenesis<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and cardiovascular disease<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Specificity protein 1 (SP1) is associated with different types of cancer, neurological and cardiovascular disease<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup> and ZNF341 is involved in immune-mediated disorders and infection susceptibility by regulating IL-6 signaling<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. BCL11A is involved in β-hemoglobinopathies, cancer and type II diabetes<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, neurogenesis<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and midbrain dopaminergic neurons<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>.</p>
              <p id="Par15">In our study we found no evidence of association between IEAA and ACE total score, probably because 90% of the participants had a history of 4 or more ACEs. However, our analyses of the three categories of adversity (i.e. abuse, neglect and household challenges), revealed a weak but significant correlation between IEAA and exposure to abuse (emotional, physical and sexual) but not to the other ACE categories. These findings are consistent with data from a prospective study with 974 children showing that girls from age 0–14 years exposed to abuse (i.e., emotional or physical), but not to other individual types of ACEs, presented DNA methylation age acceleration<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. On the other hand, no effect in the epigenetic aging trajectory was detected in response to the intervention, probably due to its short duration. Future prospective studies including follow-up care and evaluation will be required to explore a putative association of the intervention with changes in the epigenetic aging trajectory in subjects with a history of multiple ACEs.</p>
              <p id="Par16">The DNA methylation changes post-intervention correlated with the CPSS, SPRINT and MAAS-A measured psychological outcomes at 202, 160, and 274 CpGs, respectively. However, only two of these DML, annotated to the <italic>SIRT5</italic> and <italic>TRAPPC2L</italic> genes, showed a change in DNA methylation level greater than 5% (<italic>p</italic> value &lt; 0.001). <italic>SIRT5</italic> (change in DNA methylation = 13%) was associated with CPSS scores and <italic>TRAPPC2L</italic> (change in DNA methylation = 7%) was associated with SPRINT scores. <italic>SIRT5</italic> is a member of the sirtuin family of proteins located predominantly in the mitochondrial matrix, and it protects cells from oxidative stress<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. The effect of traumatic stress on oxidative components and redox-state homeostasis has been documented<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. These data suggest that the epigenetic modulation of antioxidant-related pathways may be relevant to the psychological benefits of the intervention. SPRINT scores negatively correlated with the DNA methylation levels at the body of <italic>TRAPPC2L</italic> gene, which is involved in intracellular vesicle-mediated transport events<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> and is functionally associated with neurodevelopmental delay/intellectual disabilities in individuals homozygous for a missense variant<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>.</p>
              <p id="Par17">Taken together, our data support the contribution of epigenetic mechanisms in mediating the effects of the 1-week intervention group program for adolescents exposed to 4 or more ACEs. Future studies are required to examine the functional implications of these changes (i.e., expression levels and activity of candidate genes). The potential relationships of these findings with physiological outcomes may help identify molecular targets aimed to prevent the onset of health disorders and improve the long-term health trajectory in individuals with 4 or more ACEs. Although this level of exposure to adversity increases the risk of adult onset of chronic health problems, behavioral risk, and mortality<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, ACE screening is not yet integrated into primary care. One of the arguments is the scarce evidence on therapeutic strategies for children or adolescents with a history of multiple victimization<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. However, the early screening of ACEs is seen by several authors as a promising way to promote child well-being through policy, health education and evidence-based programs for families, children and adolescents<sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup>. Results presented in our previous study<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, data presented here and recent evidence from other studies<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup> are starting to provide the scientific background to encourage further discussions on future avenues for prevention and treatment of ACEs. Although this study describes a promising short intervention for adolescents with multiple ACEs, the participants may still need group or individual follow-up support in order to enhance and strengthen the benefits from this program. Future prospective studies to assess the stability of the epigenetic changes resulting from the intervention and their potential long-term influence on health are warranted.</p>
            </sec>
            <sec id="Sec8">
              <title>Methods</title>
              <sec id="Sec9">
                <title>Participants</title>
                <p id="Par18">We recruited forty-four adolescent girls, aged 13–16 years, from the foster care system of the Colombian Institute of Family Well-Being (ICBF). All participants were partially or totally separated from their biological families due to inadequate parental care, including abuse and neglect. Exclusion criteria were cognitive impairment, self-harming behavior within the last 6 months, suicidal behavior or ideation or current substance dependence. The flowchart of participants invited, screened, enrolled and completing the study as well as the participants’ demographic information that we could collect have been fully described in our previous report<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Participants and their legal representatives provided a written informed consent. We randomized the participants into two groups using a random-number generator. All subjects (intervention and control group; n = 44) underwent parallel and identical assessments at baseline and post-intervention. Participants were informed to which group they had been assigned after the baseline assessment (T1) and subjects assigned to the control group were immediately invited to attend the same program at the end of the study. All the assessments were carried out at the youth care centers from which the participants were recruited.</p>
                <p id="Par19">This research was performed in accordance with relevant guidelines/regulations and in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants and their legal guardians.</p>
              </sec>
              <sec id="Sec10">
                <title>Intervention</title>
                <p id="Par20">The intervention was performed during a school holiday week (June 20–27th, 2019) and it was conducted at a nature retreat facility in Santander, Colombia.</p>
                <p id="Par21">The intervention program included an early morning routine starting with an awakening with soft music and a hot beverage in the garden, followed by a 30 min yoga session<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> and a guided loving kindness and compassion meditation to cultivate positive affective states<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. After a healthy breakfast, participants attended a mindfulness practice for adolescents<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. The program included several sessions per day of artistic expression through art and craft, dramatic play, dance, and music. On days 5 and 6, participants attended two EMDR group protocol sessions/day. During that same week, the control group was engaged in holiday activities proposed by the ICBF. While the intervention and the control group, in their respective locations, engaged in some similar activities (e.g., dance, acting, physical exercise, games, movies), the control group activities did not include approaches to specifically treat traumatic experiences or to promote attentional and emotional regulation. For full details of the intervention program and the control group activities, see Roque López et al.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p>
              </sec>
              <sec id="Sec11">
                <title>DNA Isolation and Methylation microarray</title>
                <p id="Par22">Before and after the 1-week intervention, saliva samples (1 ml) from all the participants (n = 22/group) were collected using Oragene saliva collection kits and DNA was isolated according to the manufacturer’s protocol. DNA concentration was determined using a Qubit fluorometer (Life Technologies) and normalized to 20 ng/μl for the methylation microarray. Bisulfite conversion was performed with the EZ methylation Gold-kit (cat# D5005, Zymo Research) and the Illumina Infinium MethylationEPIC Beadchip Array was used to quantitatively interrogate at single-nucleotide resolution over 850,000 CpG sites across the genome (Biotech Center, University of Wisconsin-Madison).</p>
              </sec>
              <sec id="Sec12">
                <title>Pre-processing of human MethylationEPIC data</title>
                <p id="Par23">Raw intensity data files were imported into R environment. R package minfi was used to assess sample quality, calculate the detection <italic>p</italic> value of each tested probe, and normalize data<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. Two samples were discarded as their mean detection <italic>p</italic> value exceeded 0.05. Probes were normal-exponential out-of-band (noob) normalized with dye correction, followed by quantile normalization. No samples showed incorrect sex prediction based on methylation levels. Probes were filtered if at most one sample exhibited a detection <italic>p</italic> value &gt; 0.01, contained a SNP, reported methylation at a SNP, measured methylation at a CH dinucleotide site, had at most one sample with a detection <italic>p</italic> value &gt; 0.01 or were known cross-reactive probes<sup><xref ref-type="bibr" rid="CR71">71</xref>,<xref ref-type="bibr" rid="CR72">72</xref></sup>. These filtration criteria resulted in 688,000 probes used for further analysis.</p>
                <p id="Par24">Beta values were obtained through minfi and were further converted to M-values for differential analysis.</p>
              </sec>
              <sec id="Sec13">
                <title>Identification of differentially methylated loci (DML)</title>
                <p id="Par25">Linear regression for each tested CpG using an ANCOVA model was employed using R package limma<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. The treatment effect (difference between the intervention and control group) on DNA methylation level, was estimated using an analysis of covariance (ANCOVA) of the outcome (T2) with the baseline (T1) as covariate. BMI, age, ACE score and cell type proportions (surrogate variables) were also included as covariates. In this model, the mean posttest difference between the groups is used to estimate the outcome (DNAm T2 ~ Group (control/int) + age + bmi + ACE + DNAm T1 + surrogate variables)<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Surrogate variables were assessed by R package sva<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, which identified a total of 3 variables. For quality control purposes cell type proportions were also calculated using R package RefFreeEWAS. The correlation of <italic>p</italic> values between these two approaches was 0.86, indicating the accuracy of both measures. <italic>P</italic> values corrected and uncorrected by FDR were obtained. To assess systematic bias of the linear regression model, the genomic inflation factor was calculated for the obtained <italic>p</italic> values, yielding a genomic inflation factor of ~ 1, suggesting no bias in these methods. In our study, the relatively small sample size, together with some characteristics inherent to the array (measure of continuous variables in large cell numbers, non-variability of many sites on the array, correlation between neighboring probes on the array) likely resulted in the absence of FDR adjusted DML<sup><xref ref-type="bibr" rid="CR76">76</xref>,<xref ref-type="bibr" rid="CR77">77</xref></sup>. However, an FDR adjustment assumes independence in the comparisons, and DNA methylation levels across the genome are not independent. Thus, several studies have taken an approach that requires a larger effect size (i.e., &gt; 10%) with a more liberal <italic>p</italic> value cut-off<sup><xref ref-type="bibr" rid="CR78">78</xref>–<xref ref-type="bibr" rid="CR81">81</xref></sup>. Therefore, to detect intervention-sensitive DML, we established as cut-off a <italic>p</italic> value ≤ 0.001 combined with an average difference in methylation between T1 and T2 greater than 10%.</p>
              </sec>
              <sec id="Sec14">
                <title>Functional analysis</title>
                <p id="Par26">Gene ontological enrichment of biological processes were identified using the ConsensusPathDB-human database as implemented in the Functional Enrichment module of the EASIER R package<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. This database integrates interaction networks in Homo sapiens including metabolic, biochemical and gene regulatory signaling and drug-target interactions. FDR-corrected <italic>p</italic> values &lt; 0.05 were considered significant.</p>
                <p id="Par27">The DNA sequences flanking the DML of (+ /− 250 nucleotides) were used to find enriched motifs using the AME suite package (MEME Suite online platform)<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. An E-value cut-off of 0.05 was established to identify significantly enriched motifs, as recommended by MEME developers<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>.</p>
              </sec>
              <sec id="Sec15">
                <title>Estimation of the impact of the multimodal intervention on epigenetic age acceleration</title>
                <p id="Par28">We explored the associations between Intrinsic Epigenetic Age Acceleration (IEAA) and ACE scores using the basal DNA methylation data from both groups and the ACE scores that we previously described in the same sample<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Child epigenetic age based on the Pediatric-Buccal-Epigenetics’ (PedBE) clock<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> was calculated using the methylclock R package<sup><xref ref-type="bibr" rid="CR84">84</xref></sup>. The package provides the following parameters: (i) DNA methylation predicted age (biological age) in years, (ii) age acceleration, difference between DNAm and chronological age in years; (iii) Intrinsic Epigenetic Age Acceleration (IEAA), obtained after regressing chronological age and cell type proportions on biological age. Pearson's correlation analysis was used to explore associations between basal Intrinsic Epigenetic Age Acceleration (IEAA) adjusted by cell type proportions, ACE total score and the number of ACEs from each one of the three categories of adversity (i.e. abuse: emotional, physical and sexual; neglect: emotional and physical; household dysfunction: separation from biological parents, witnessing domestic violence, household substance abuse, mental illness in household and having incarcerated family members), assessed by the 10-item ACE questionnaire derived from the Kaiser Permanente ACEs Study<sup><xref ref-type="bibr" rid="CR85">85</xref></sup> (full details on frequency and patterns of ACEs in this sample are described in Roque Lopez et al.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>). We used an ANCOVA model (see “<xref rid="Sec13" ref-type="sec">Methods</xref>”) to assess the potential impact of the intervention on IEAA. This model included group (intervention or control) as the independent variable, IEAA at T2 from both groups as the dependent variable, and it was adjusted by basal IEAA (T1), BMI, and ACE score, considering <italic>p</italic> values &lt; 0.05 as significant.</p>
              </sec>
              <sec id="Sec16">
                <title>Correlation between psychological phenotypic measures and DNA methylation</title>
                <p id="Par29">PTSD and awareness and attention-related outcomes of this intervention in this same sample were assessed by SPRINT, CPSS and MAAS-A scales and are fully reported in our previous report<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Here we conducted correlations between changes in the above-mentioned scales and changes in DNA methylation (T2−T1) of each CpG.</p>
                <p id="Par30">Linear regression for each tested CpG using an ANCOVA model was employed using R package limma<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Separate models for each psychological scale were constructed, controlling for age, BMI and ACES score. Surrogate variables were assessed by the R package sva<sup><xref ref-type="bibr" rid="CR75">75</xref></sup><italic>.</italic> To assess systematic bias of the linear regression model, the genomic inflation factor was calculated for the obtained <italic>p</italic> values, yielding a genomic inflation factor of ~ 1, suggesting no bias. Pearson’s correlation coefficients (r) were calculated for continuous variables of interest with beta-values. Correlations with an uncorrected <italic>p</italic> value &lt; 1 × 10<sup>–3</sup>, and a correlation coefficient r &gt; 0.5 were considered significant for the current study.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec17">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41598_2022_21246_MOESM1_ESM.xlsx">
                      <caption>
                        <p>Supplementary Information.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
              <fn>
                <p>These authors contributed equally: Marta Cosín-Tomás and Andy Madrid.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary Information</title>
              <p>The online version contains supplementary material available at 10.1038/s41598-022-21246-9.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>We thank the IIDC staff; the participants for volunteering in this study; the Colombian Institute of Family Well-Being (ICBF) and the therapeutic team. Special thanks to Dr. Jesús Julio Gómez Galvis for his precious support in the EMDR therapy with youth.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>P.K.; E.LL.-A.; S.R.L.: Concept, experimental design and data acquisition; S.R.-L.: multimodal program design; P.K., M.C.-T., A.M., L.P., R.S.A., R.J.D.: data analysis/interpretation; P.K., M.C.-T.: drafting of the manuscript; R.S.A., R.J.D: critical revision of the manuscript; R.J.D, P.K., E.LL.-A., S.R.-L.: funding acquisition. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This work was supported by grants to ELL (Universidad de Santander UDES and Fundación Mindfulness Colombia). We thank Immobilière pour l’Amenagement des Campus Universitaires, IAC (France) and King Philanthropies for their generous gifts to IIDC and to the Center for Healthy Minds, respectively, and the University of Wisconsin department of Neurological Surgery, all of which helped to support this work. This research was reviewed and approved by the Institutional Review Board of the University of Santander, Bucaramanga, Colombia (CBU-FT002-UDES; act #031, 11/22/2018) and the Review Board of the University of Wisconsin, Madison (IRB number 2019-1089).</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par31">The program described in this study was designed by author Susana Roque-López, founder and director of the nonprofit organization Association Innocence in Danger Colombia (IIDC).</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gordon</surname>
                      <given-names>JB</given-names>
                    </name>
                  </person-group>
                  <article-title>The importance of child abuse and neglect in adult medicine</article-title>
                  <source>Pharmacol. Biochem. Behav.</source>
                  <year>2021</year>
                  <pub-id pub-id-type="doi">10.1016/j.pbb.2021.173268</pub-id>
                  <?supplied-pmid 34499948?>
                  <pub-id pub-id-type="pmid">34499948</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bellis</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Hughes</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ramos Rodriguez</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Sethi</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Passmore</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Life course health consequences and associated annual costs of adverse childhood experiences across Europe and North America: A systematic review and meta-analysis</article-title>
                  <source>Lancet Public Health</source>
                  <year>2019</year>
                  <volume>4</volume>
                  <fpage>e517</fpage>
                  <lpage>e528</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2468-2667(19)30145-8</pub-id>
                  <?supplied-pmid 31492648?>
                  <pub-id pub-id-type="pmid">31492648</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hughes</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The effect of multiple adverse childhood experiences on health: A systematic review and meta-analysis</article-title>
                  <source>Lancet Public Health</source>
                  <year>2017</year>
                  <volume>2</volume>
                  <fpage>e356</fpage>
                  <lpage>e366</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2468-2667(17)30118-4</pub-id>
                  <pub-id pub-id-type="pmid">29253477</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berger</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Kouzarides</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Shiekhattar</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Shilatifard</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>An operational definition of epigenetics</article-title>
                  <source>Genes Dev.</source>
                  <year>2009</year>
                  <pub-id pub-id-type="doi">10.1101/gad.1787609</pub-id>
                  <?supplied-pmid 19339683?>
                  <pub-id pub-id-type="pmid">19339683</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goldberg</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Allis</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Epigenetics: A landscape takes shape</article-title>
                  <source>Cell</source>
                  <year>2007</year>
                  <volume>128</volume>
                  <issue>4</issue>
                  <fpage>635</fpage>
                  <lpage>638</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cell.2007.02.006</pub-id>
                  <?supplied-pmid 17320500?>
                  <pub-id pub-id-type="pmid">17320500</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cattaneo</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Inflammation and neuronal plasticity: A link between childhood trauma and depression pathogenesis</article-title>
                  <source>Front. Cell Neurosci.</source>
                  <year>2015</year>
                  <volume>9</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.3389/fncel.2015.00040</pub-id>
                  <pub-id pub-id-type="pmid">25667569</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Park</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neuroscience and biobehavioral reviews stress, epigenetics and depression : A systematic review</article-title>
                  <source>Neurosci. Biobehav. Rev.</source>
                  <year>2019</year>
                  <volume>102</volume>
                  <fpage>139</fpage>
                  <lpage>152</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neubiorev.2019.04.010</pub-id>
                  <pub-id pub-id-type="pmid">31005627</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Janusek</surname>
                      <given-names>LW</given-names>
                    </name>
                    <name>
                      <surname>Tell</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Gaylord-Harden</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Mathews</surname>
                      <given-names>HL</given-names>
                    </name>
                  </person-group>
                  <article-title>Relationship of childhood adversity and neighborhood violence to a proinflammatory phenotype in emerging adult African American men: An epigenetic link</article-title>
                  <source>Brain. Behav. Immun.</source>
                  <year>2017</year>
                  <volume>60</volume>
                  <fpage>126</fpage>
                  <lpage>135</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2016.10.006</pub-id>
                  <?supplied-pmid 27765646?>
                  <pub-id pub-id-type="pmid">27765646</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Turecki</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Meaney</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of the social environment and stress on glucocorticoid receptor gene methylation: A systematic review</article-title>
                  <source>Biol. Psychiat.</source>
                  <year>2016</year>
                  <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.11.022</pub-id>
                  <?supplied-pmid 27773352?>
                  <pub-id pub-id-type="pmid">27773352</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Krause</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Artigas</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Sciolla</surname>
                      <given-names>AF</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Epigenetic mechanisms activated by childhood adversity</article-title>
                  <source>Epigenomics</source>
                  <year>2020</year>
                  <volume>12</volume>
                  <issue>14</issue>
                  <fpage>1239</fpage>
                  <lpage>1255</lpage>
                  <pub-id pub-id-type="doi">10.2217/epi-2020-0042</pub-id>
                  <?supplied-pmid 32706263?>
                  <pub-id pub-id-type="pmid">32706263</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zannas</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Wiechmann</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Gassen</surname>
                      <given-names>NC</given-names>
                    </name>
                    <name>
                      <surname>Binder</surname>
                      <given-names>EB</given-names>
                    </name>
                  </person-group>
                  <article-title>Gene-stress-epigenetic regulation of FKBP5: Clinical and translational implications</article-title>
                  <source>Neuropsychopharmacology</source>
                  <year>2016</year>
                  <pub-id pub-id-type="doi">10.1038/npp.2015.235</pub-id>
                  <?supplied-pmid 26250598?>
                  <pub-id pub-id-type="pmid">26250598</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Papale</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Seltzer</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Madrid</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pollak</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Alisch</surname>
                      <given-names>RS</given-names>
                    </name>
                  </person-group>
                  <article-title>Differentially methylated genes in saliva are linked to childhood stress</article-title>
                  <source>Sci. Rep.</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-018-29107-0</pub-id>
                  <pub-id pub-id-type="pmid">29311619</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Almeida</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin receptor expression and epigenetic regulation in the anterior cingulate cortex of individuals with a history of severe childhood abuse</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2022</year>
                  <volume>136</volume>
                  <fpage>105600</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.psyneuen.2021.105600</pub-id>
                  <?supplied-pmid 34839083?>
                  <pub-id pub-id-type="pmid">34839083</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kundakovic</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gudsnuk</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Herbstman</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Perera</surname>
                      <given-names>FP</given-names>
                    </name>
                    <name>
                      <surname>Champagne</surname>
                      <given-names>FA</given-names>
                    </name>
                  </person-group>
                  <article-title>DNA methylation of BDNF as a biomarker of early-life adversity</article-title>
                  <source>Proc. Natl. Acad. Sci. U. S. A.</source>
                  <year>2015</year>
                  <volume>112</volume>
                  <issue>22</issue>
                  <fpage>6807</fpage>
                  <lpage>6813</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1408355111</pub-id>
                  <?supplied-pmid 25385582?>
                  <pub-id pub-id-type="pmid">25385582</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Engdahl</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Alavian-Ghavanini</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Forsell</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Lavebratt</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Rüegg</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Childhood adversity increases methylation in the GRIN2B gene</article-title>
                  <source>J. Psychiatr. Res.</source>
                  <year>2021</year>
                  <volume>132</volume>
                  <fpage>38</fpage>
                  <lpage>43</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpsychires.2020.09.022</pub-id>
                  <?supplied-pmid 33038564?>
                  <pub-id pub-id-type="pmid">33038564</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Essex</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Epigenetic vestiges of early developmental adversity: Childhood stress exposure and DNA methylation in adolescence</article-title>
                  <source>Child Dev.</source>
                  <year>2013</year>
                  <pub-id pub-id-type="doi">10.1111/j.1467-8624.2011.01641.x</pub-id>
                  <?supplied-pmid 21883162?>
                  <pub-id pub-id-type="pmid">21883162</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Radtke</surname>
                      <given-names>KM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Epigenetic modifications of the glucocorticoid receptor gene are associated with the vulnerability to psychopathology in childhood maltreatment</article-title>
                  <source>Transl. Psychiatry</source>
                  <year>2015</year>
                  <pub-id pub-id-type="doi">10.1038/tp.2015.63</pub-id>
                  <?supplied-pmid 26080088?>
                  <pub-id pub-id-type="pmid">26080088</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marini</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adversity exposure during sensitive periods predicts accelerated epigenetic aging in children</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2020</year>
                  <volume>113</volume>
                  <fpage>104484</fpage>
                  <lpage>104492</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.psyneuen.2019.104484.Adversity</pub-id>
                  <?supplied-pmid 31918390?>
                  <pub-id pub-id-type="pmid">31918390</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hannum</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome-wide methylation profiles reveal quantitative views of human aging rates</article-title>
                  <source>Mol. Cell</source>
                  <year>2013</year>
                  <pub-id pub-id-type="doi">10.1016/j.molcel.2012.10.016</pub-id>
                  <?supplied-pmid 23177740?>
                  <pub-id pub-id-type="pmid">23177740</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levine</surname>
                      <given-names>ME</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An epigenetic biomarker of aging for lifespan and healthspan</article-title>
                  <source>Aging</source>
                  <year>2018</year>
                  <pub-id pub-id-type="doi">10.18632/aging.101414</pub-id>
                  <?supplied-pmid 29676998?>
                  <pub-id pub-id-type="pmid">29676998</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McEwen</surname>
                      <given-names>LM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The PedBE clock accurately estimates DNA methylation age in pediatric buccal cells</article-title>
                  <source>Proc. Natl. Acad. Sci. U. S. A.</source>
                  <year>2020</year>
                  <volume>117</volume>
                  <issue>38</issue>
                  <fpage>23329</fpage>
                  <lpage>23335</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1820843116</pub-id>
                  <?supplied-pmid 31611402?>
                  <pub-id pub-id-type="pmid">31611402</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horvath</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>DNA methylation age of human tissues and cell types</article-title>
                  <source>Genome Biol.</source>
                  <year>2013</year>
                  <pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id>
                  <?supplied-pmid 24138928?>
                  <pub-id pub-id-type="pmid">24138928</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brody</surname>
                      <given-names>GH</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Beach</surname>
                      <given-names>SRH</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>GE</given-names>
                    </name>
                  </person-group>
                  <article-title>Family-centered prevention ameliorates the longitudinal association between risky family processes and epigenetic aging</article-title>
                  <source>J. Child Psychol. Psychiatry Allied Discip.</source>
                  <year>2016</year>
                  <pub-id pub-id-type="doi">10.1111/jcpp.12495</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jovanovic</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Exposure to violence accelerates epigenetic aging in children</article-title>
                  <source>Sci. Rep.</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-09235-9</pub-id>
                  <pub-id pub-id-type="pmid">28127051</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Palma-Gudiel</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Fañanás</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Horvath</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Zannas</surname>
                      <given-names>AS</given-names>
                    </name>
                  </person-group>
                  <source>Psychosocial Stress and Epigenetic Aging</source>
                  <year>2020</year>
                  <publisher-name>Elsevier Inc.</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horvath</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Raj</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>DNA methylation-based biomarkers and the epigenetic clock theory of ageing</article-title>
                  <source>Nat. Rev. Genet.</source>
                  <year>2018</year>
                  <volume>19</volume>
                  <issue>6</issue>
                  <fpage>371</fpage>
                  <lpage>384</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41576-018-0004-3</pub-id>
                  <?supplied-pmid 29643443?>
                  <pub-id pub-id-type="pmid">29643443</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Crandall</surname>
                      <given-names>AA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>ACEs and counter-ACEs: How positive and negative childhood experiences influence adult health</article-title>
                  <source>Child Abus. Negl.</source>
                  <year>2019</year>
                  <volume>96</volume>
                  <fpage>104089</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.chiabu.2019.104089</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Qu</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Positive childhood experiences can moderate the impact of adverse childhood experiences on adolescent depression and anxiety: Results from a cross-sectional survey</article-title>
                  <source>Child Abus. Negl.</source>
                  <year>2022</year>
                  <volume>125</volume>
                  <fpage>105511</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.chiabu.2022.105511</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bethell</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gombojav</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Linkenbach</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Sege</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Positive childhood experiences and adult mental and relational health in a statewide sample: Associations across adverse childhood experiences levels</article-title>
                  <source>JAMA Pediatr.</source>
                  <year>2019</year>
                  <pub-id pub-id-type="doi">10.1001/jamapediatrics.2019.3007</pub-id>
                  <?supplied-pmid 31498386?>
                  <pub-id pub-id-type="pmid">31498386</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Whitaker</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Dearth-Wesley</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Herman</surname>
                      <given-names>AN</given-names>
                    </name>
                  </person-group>
                  <article-title>Childhood family connection and adult flourishing: Associations across levels of childhood adversity</article-title>
                  <source>Acad. Pediatr.</source>
                  <year>2021</year>
                  <volume>21</volume>
                  <issue>8</issue>
                  <fpage>1380</fpage>
                  <lpage>1387</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.acap.2021.03.002</pub-id>
                  <?supplied-pmid 33713838?>
                  <pub-id pub-id-type="pmid">33713838</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Silverstone</surname>
                      <given-names>PH</given-names>
                    </name>
                    <name>
                      <surname>Suen</surname>
                      <given-names>VYM</given-names>
                    </name>
                  </person-group>
                  <article-title>Are complex multimodal interventions the best treatments for mental health disorders in children and youth?</article-title>
                  <source>J. Child Adolesc. Behav.</source>
                  <year>2016</year>
                  <pub-id pub-id-type="doi">10.4172/2375-4494.1000305</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reeson</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A novel 2-week intensive multimodal treatment program for child sexual abuse (CSA) survivors is associated with mental health benefits for females aged 13–16</article-title>
                  <source>J. Can. Acad. Child Adolesc. Psychiatry</source>
                  <year>2020</year>
                  <volume>29</volume>
                  <issue>3</issue>
                  <fpage>165</fpage>
                  <lpage>176</lpage>
                  <?supplied-pmid 32774399?>
                  <pub-id pub-id-type="pmid">32774399</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nithianantharajah</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hannan</surname>
                      <given-names>AJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Enriched environments, experience- dependent plasticity and disorders of the nervous system</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2006</year>
                  <volume>7</volume>
                  <issue>9</issue>
                  <fpage>697</fpage>
                  <lpage>709</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrn1970</pub-id>
                  <?supplied-pmid 16924259?>
                  <pub-id pub-id-type="pmid">16924259</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Queen</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Hassan</surname>
                      <given-names>QN</given-names>
                    </name>
                    <name>
                      <surname>Cao</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Improvements to healthspan through environmental enrichment and lifestyle interventions: Where are we now?</article-title>
                  <source>Front. Neurosci.</source>
                  <year>2020</year>
                  <volume>14</volume>
                  <fpage>1</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="doi">10.3389/fnins.2020.00605</pub-id>
                  <pub-id pub-id-type="pmid">32038151</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Borba</surname>
                      <given-names>LA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Environmental enrichment improves lifelong persistent behavioral and epigenetic changes induced by early-life stress</article-title>
                  <source>J. Psychiatr. Res.</source>
                  <year>2021</year>
                  <volume>138</volume>
                  <fpage>107</fpage>
                  <lpage>116</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpsychires.2021.04.008</pub-id>
                  <?supplied-pmid 33848966?>
                  <pub-id pub-id-type="pmid">33848966</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roque-Lopez</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mental health benefits of a 1-week intensive multimodal group program for adolescents with multiple adverse childhood experiences</article-title>
                  <source>Child Abus. Negl.</source>
                  <year>2021</year>
                  <volume>122</volume>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.chiabu.2021.105349</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aran</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Toperoff</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Rosenberg</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hellman</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Replication timing-related and gene body-specific methylation of active human genes</article-title>
                  <source>Hum. Mol. Genet.</source>
                  <year>2011</year>
                  <volume>20</volume>
                  <issue>4</issue>
                  <fpage>670</fpage>
                  <lpage>680</lpage>
                  <pub-id pub-id-type="doi">10.1093/hmg/ddq513</pub-id>
                  <?supplied-pmid 21112978?>
                  <pub-id pub-id-type="pmid">21112978</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Massart</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells</article-title>
                  <source>Sci. Rep.</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>1</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1038/srep19615</pub-id>
                  <pub-id pub-id-type="pmid">28442746</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Provençal</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells</article-title>
                  <source>J. Neurosci.</source>
                  <year>2012</year>
                  <volume>32</volume>
                  <issue>44</issue>
                  <fpage>15626</fpage>
                  <lpage>15642</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1470-12.2012</pub-id>
                  <?supplied-pmid 23115197?>
                  <pub-id pub-id-type="pmid">23115197</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davies</surname>
                      <given-names>MN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood</article-title>
                  <source>Genome Biol.</source>
                  <year>2012</year>
                  <pub-id pub-id-type="doi">10.1186/gb-2012-13-6-r43</pub-id>
                  <?supplied-pmid 22703893?>
                  <pub-id pub-id-type="pmid">22703893</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>AK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>DNA extracted from saliva for methylation studies of psychiatric traits: Evidence tissue specificity and relatedness to brain</article-title>
                  <source>Am. J. Med. Genet. Part B Neuropsychiatr. Genet.</source>
                  <year>2015</year>
                  <volume>168</volume>
                  <fpage>36</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1002/ajmg.b.32278</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Czarny</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Wigner</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Galecki</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Sliwinski</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression</article-title>
                  <source>Prog. Neuro Psychopharmacol. Biol. Psychiatry</source>
                  <year>2018</year>
                  <volume>80</volume>
                  <issue>June</issue>
                  <fpage>309</fpage>
                  <lpage>321</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.06.036</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Iwata</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ota</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Duman</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses</article-title>
                  <source>Brain Behav. Immun.</source>
                  <year>2013</year>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2012.12.008</pub-id>
                  <?supplied-pmid 23261775?>
                  <pub-id pub-id-type="pmid">23261775</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Achenbach</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neurohumoral profiles and childhood adversity of patients with multisomatoform disorder and pain as the leading bodily symptom</article-title>
                  <source>Dis. Markers</source>
                  <year>2022</year>
                  <volume>2022</volume>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1155/2022/7958375</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vella</surname>
                      <given-names>KR</given-names>
                    </name>
                    <name>
                      <surname>Hollenberg</surname>
                      <given-names>AN</given-names>
                    </name>
                  </person-group>
                  <article-title>Early life stress affects the HPT axis response in a sexually dimorphic manner</article-title>
                  <source>Endocrinology</source>
                  <year>2021</year>
                  <volume>162</volume>
                  <issue>9</issue>
                  <fpage>1</fpage>
                  <lpage>2</lpage>
                  <pub-id pub-id-type="doi">10.1210/endocr/bqab137</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>King</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Graber</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Colich</surname>
                      <given-names>NL</given-names>
                    </name>
                    <name>
                      <surname>Gotlib</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>Associations of waking cortisol with DHEA and testosterone across the pubertal transition: Effects of threat-related early life stress</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2019</year>
                  <volume>115</volume>
                  <fpage>2020</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.psyneuen.2020.104651</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Terock</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Differential activation of the renin-angiotensin-aldosterone-system in response to childhood and adulthood trauma</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2019</year>
                  <volume>107</volume>
                  <fpage>232</fpage>
                  <lpage>240</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.psyneuen.2019.05.026</pub-id>
                  <?supplied-pmid 31174161?>
                  <pub-id pub-id-type="pmid">31174161</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oh</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Shin</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Janknecht</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors</article-title>
                  <source>Biochim. Biophys. Acta Rev. Cancer</source>
                  <year>2012</year>
                  <volume>1826</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbcan.2012.02.002</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>ETV2/ER71 transcription factor as a therapeutic vehicle for cardiovascular disease</article-title>
                  <source>Theranostics</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <issue>19</issue>
                  <fpage>5694</fpage>
                  <lpage>5705</lpage>
                  <pub-id pub-id-type="doi">10.7150/thno.35300</pub-id>
                  <?supplied-pmid 31534512?>
                  <pub-id pub-id-type="pmid">31534512</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O’Connor</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Gilmour</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bonifer</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of the ubiquitously expressed transcription factor Sp1 in tissue-specific transcriptional regulation and in disease</article-title>
                  <source>Yale J. Biol. Med.</source>
                  <year>2016</year>
                  <volume>89</volume>
                  <issue>4</issue>
                  <fpage>513</fpage>
                  <lpage>525</lpage>
                  <?supplied-pmid 28018142?>
                  <pub-id pub-id-type="pmid">28018142</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Sheng</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Structure, regulation, and biological functions of TIGAR and its role in diseases</article-title>
                  <source>Acta Pharmacol. Sin.</source>
                  <year>2021</year>
                  <volume>42</volume>
                  <issue>10</issue>
                  <fpage>1547</fpage>
                  <lpage>1555</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41401-020-00588-y</pub-id>
                  <?supplied-pmid 33510458?>
                  <pub-id pub-id-type="pmid">33510458</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Freeman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Milner</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>The child with elevated IgE and infection susceptibility</article-title>
                  <source>Curr. Allergy Asthma Rep.</source>
                  <year>2020</year>
                  <volume>24</volume>
                  <issue>20</issue>
                  <fpage>65</fpage>
                  <pub-id pub-id-type="doi">10.1007/s11882-020-00964-y</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Xie</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Ye</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Che</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>BCL11A: A potential diagnostic biomarker and therapeutic target in human diseases</article-title>
                  <source>Biosci. Rep.</source>
                  <year>2019</year>
                  <volume>39</volume>
                  <issue>11</issue>
                  <fpage>1</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1042/BSR20190604</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Du</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Transcription factors Bcl11a and Bcl11b are required for the production and differentiation of cortical projection neurons</article-title>
                  <source>Cereb. Cortex</source>
                  <year>2021</year>
                  <pub-id pub-id-type="doi">10.1093/cercor/bhab437</pub-id>
                  <?supplied-pmid 34265850?>
                  <pub-id pub-id-type="pmid">34265850</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tolve</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons</article-title>
                  <source>Cell Rep.</source>
                  <year>2021</year>
                  <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109697</pub-id>
                  <?supplied-pmid 34525371?>
                  <pub-id pub-id-type="pmid">34525371</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tang</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Howe</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Suderman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Relton</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Crawford</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Houtepen</surname>
                      <given-names>LC</given-names>
                    </name>
                  </person-group>
                  <article-title>Adverse childhood experiences, DNA methylation age acceleration, and cortisol in UK children: A prospective population-based cohort study</article-title>
                  <source>Clin. Epigenetics</source>
                  <year>2020</year>
                  <volume>12</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13148-020-00844-2</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van de Ven</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Haigis</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Mitochondrial sirtuins and molecular mechanisms of aging</article-title>
                  <source>Trends Mol. Med.</source>
                  <year>2017</year>
                  <volume>23</volume>
                  <fpage>320</fpage>
                  <lpage>331</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.molmed.2017.02.005</pub-id>
                  <?supplied-pmid 28285806?>
                  <pub-id pub-id-type="pmid">28285806</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ji</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>GH</given-names>
                    </name>
                    <name>
                      <surname>Qu</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Mitochondrial sirtuins, metabolism, and aging</article-title>
                  <source>J. Genet. Genomics</source>
                  <year>2022</year>
                  <pub-id pub-id-type="doi">10.1016/j.jgg.2021.11.005</pub-id>
                  <?supplied-pmid 35331929?>
                  <pub-id pub-id-type="pmid">35331929</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Karanikas</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Daskalakis</surname>
                      <given-names>NP</given-names>
                    </name>
                    <name>
                      <surname>Agorastos</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxidative dysregulation in early life stress and posttraumatic stress disorder: A comprehensive review</article-title>
                  <source>Brain Sci.</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>6</issue>
                  <fpage>1</fpage>
                  <lpage>28</lpage>
                  <pub-id pub-id-type="doi">10.3390/brainsci11060723</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scrivens</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Shahrzad</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Moores</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Morin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Brunet</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sacher</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>TRAPPC2L is a novel, highly conserved TRAPP-interacting protein</article-title>
                  <source>Traffic</source>
                  <year>2009</year>
                  <volume>10</volume>
                  <issue>6</issue>
                  <fpage>724</fpage>
                  <lpage>736</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1600-0854.2009.00906.x</pub-id>
                  <?supplied-pmid 19416478?>
                  <pub-id pub-id-type="pmid">19416478</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Al-Deri</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A novel homozygous variant in TRAPPC2L results in a neurodevelopmental disorder and disrupts TRAPP complex function</article-title>
                  <source>J. Med. Genet.</source>
                  <year>2021</year>
                  <volume>58</volume>
                  <issue>9</issue>
                  <fpage>592</fpage>
                  <lpage>601</lpage>
                  <pub-id pub-id-type="doi">10.1136/jmedgenet-2020-107016</pub-id>
                  <?supplied-pmid 32843486?>
                  <pub-id pub-id-type="pmid">32843486</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Campbell</surname>
                      <given-names>TL</given-names>
                    </name>
                  </person-group>
                  <article-title>Screening for adverse childhood experiences (ACEs) in primary care: A cautionary note</article-title>
                  <source>JAMA J. Am. Med. Assoc.</source>
                  <year>2020</year>
                  <volume>323</volume>
                  <issue>23</issue>
                  <fpage>2379</fpage>
                  <lpage>2380</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2020.4365</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gordon</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Nemeroff</surname>
                      <given-names>CB</given-names>
                    </name>
                    <name>
                      <surname>Felitti</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Screening for adverse childhood experiences</article-title>
                  <source>JAMA - J. Am. Med. Assoc.</source>
                  <year>2020</year>
                  <volume>324</volume>
                  <issue>17</issue>
                  <fpage>1789</fpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2020.16449</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harris</surname>
                      <given-names>NB</given-names>
                    </name>
                  </person-group>
                  <article-title>Screening for adverse childhood experiences</article-title>
                  <source>JAMA J. Am. Med. Assoc.</source>
                  <year>2020</year>
                  <volume>324</volume>
                  <issue>17</issue>
                  <fpage>1788</fpage>
                  <lpage>1789</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2020.16452</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carleial</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>DNA methylation changes following narrative exposure therapy in a randomized controlled trial with female former child soldiers</article-title>
                  <source>Sci. Rep.</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-021-98067-9</pub-id>
                  <pub-id pub-id-type="pmid">33414495</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoye</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Cheishvili</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Yarger</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Szyf</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dozier</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Preliminary indications that the attachment and biobehavioral catch-up intervention alters DNA methylation in maltreated children</article-title>
                  <source>Dev. Psychopathol.</source>
                  <year>2020</year>
                  <volume>4</volume>
                  <issue>32</issue>
                  <fpage>1486</fpage>
                  <lpage>1494</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0954579419001421</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Culver</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Whetten</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Boyd</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>O’Donnell</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Yoga to reduce trauma-related distress and emotional and behavioral difficulties among children living in orphanages in Haiti: A pilot study</article-title>
                  <source>J. Altern. Complement. Med.</source>
                  <year>2015</year>
                  <volume>21</volume>
                  <issue>9</issue>
                  <fpage>539</fpage>
                  <lpage>545</lpage>
                  <pub-id pub-id-type="doi">10.1089/acm.2015.0017</pub-id>
                  <?supplied-pmid 26090580?>
                  <pub-id pub-id-type="pmid">26090580</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nhat Hanh</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <source>You are Here: Discovering the Magic of the Present Moment</source>
                  <year>2012</year>
                  <publisher-loc>Boulder</publisher-loc>
                  <publisher-name>Shambhala Publications</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Michel</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effets de la «Mindfulness» sur l’anxiété le bien-être et les aptitudes de pleine conscience chez des élèves scolarisés du CE2 au CM2</article-title>
                  <source>Ann. Méd. Psycholo. Rev. Psychiatr.</source>
                  <year>2019</year>
                  <volume>177</volume>
                  <fpage>981</fpage>
                  <lpage>986</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.amp.2019.09.009</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aryee</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays</article-title>
                  <source>Bioinformatics</source>
                  <year>2014</year>
                  <volume>30</volume>
                  <issue>10</issue>
                  <fpage>1363</fpage>
                  <lpage>1369</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/btu049</pub-id>
                  <?supplied-pmid 24478339?>
                  <pub-id pub-id-type="pmid">24478339</pub-id>
                </element-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pidsley</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling</article-title>
                  <source>Genome Biol.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13059-016-1066-1</pub-id>
                  <pub-id pub-id-type="pmid">26753840</pub-id>
                </element-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>YA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray</article-title>
                  <source>Epigenetics</source>
                  <year>2013</year>
                  <volume>8</volume>
                  <issue>2</issue>
                  <fpage>203</fpage>
                  <lpage>209</lpage>
                  <pub-id pub-id-type="doi">10.4161/epi.23470</pub-id>
                  <?supplied-pmid 23314698?>
                  <pub-id pub-id-type="pmid">23314698</pub-id>
                </element-citation>
              </ref>
              <ref id="CR73">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ritchie</surname>
                      <given-names>ME</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <issue>7</issue>
                  <fpage>e47</fpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
                  <?supplied-pmid 25605792?>
                  <pub-id pub-id-type="pmid">25605792</pub-id>
                </element-citation>
              </ref>
              <ref id="CR74">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van Breukelen</surname>
                      <given-names>GJP</given-names>
                    </name>
                  </person-group>
                  <article-title>ANCOVA versus change from baseline had more power in randomized studies and more bias in nonrandomized studies</article-title>
                  <source>J. Clin. Epidemiol.</source>
                  <year>2006</year>
                  <volume>59</volume>
                  <issue>9</issue>
                  <fpage>920</fpage>
                  <lpage>925</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jclinepi.2006.02.007</pub-id>
                  <?supplied-pmid 16895814?>
                  <pub-id pub-id-type="pmid">16895814</pub-id>
                </element-citation>
              </ref>
              <ref id="CR75">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leek</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>WE</given-names>
                    </name>
                    <name>
                      <surname>Parker</surname>
                      <given-names>HS</given-names>
                    </name>
                    <name>
                      <surname>Jaffe</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Storey</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>The SVA package for removing batch effects and other unwanted variation in high-throughput experiments</article-title>
                  <source>Bioinformatics</source>
                  <year>2012</year>
                  <volume>28</volume>
                  <issue>6</issue>
                  <fpage>882</fpage>
                  <lpage>883</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/bts034</pub-id>
                  <?supplied-pmid 22257669?>
                  <pub-id pub-id-type="pmid">22257669</pub-id>
                </element-citation>
              </ref>
              <ref id="CR76">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Michels</surname>
                      <given-names>KB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Recommendations for the design and analysis of epigenome-wide association studies</article-title>
                  <source>Nat. Methods</source>
                  <year>2013</year>
                  <volume>10</volume>
                  <issue>10</issue>
                  <fpage>949</fpage>
                  <lpage>955</lpage>
                  <pub-id pub-id-type="doi">10.1038/nmeth.2632</pub-id>
                  <?supplied-pmid 24076989?>
                  <pub-id pub-id-type="pmid">24076989</pub-id>
                </element-citation>
              </ref>
              <ref id="CR77">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Storey</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Tibshirani</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Statistical significance for genomewide studies</article-title>
                  <source>Proc. Natl. Acad. Sci. U. S. A.</source>
                  <year>2003</year>
                  <volume>100</volume>
                  <issue>16</issue>
                  <fpage>9440</fpage>
                  <lpage>9445</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1530509100</pub-id>
                  <?supplied-pmid 12883005?>
                  <pub-id pub-id-type="pmid">12883005</pub-id>
                </element-citation>
              </ref>
              <ref id="CR78">
                <label>78.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dias</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Adam</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rheeder</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Louw</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Pheiffer</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Altered genome-wide dna methylation in peripheral blood of south african women with gestational diabetes mellitus</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2019</year>
                  <pub-id pub-id-type="doi">10.3390/ijms20235828</pub-id>
                  <?supplied-pmid 31757015?>
                  <pub-id pub-id-type="pmid">31757015</pub-id>
                </element-citation>
              </ref>
              <ref id="CR79">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Borrelli</surname>
                      <given-names>KN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of prenatal opioid exposure on the human placental methylome</article-title>
                  <source>Biomedicines</source>
                  <year>2022</year>
                  <volume>10</volume>
                  <issue>5</issue>
                  <fpage>1</fpage>
                  <lpage>16</lpage>
                  <pub-id pub-id-type="doi">10.3390/biomedicines10051150</pub-id>
                </element-citation>
              </ref>
              <ref id="CR80">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Imran</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Epigenetic programming underpins B-cell dysfunction in peanut and multi-food allergy</article-title>
                  <source>Clin. Transl. Immunol.</source>
                  <year>2021</year>
                  <pub-id pub-id-type="doi">10.1002/cti2.1324</pub-id>
                </element-citation>
              </ref>
              <ref id="CR81">
                <label>81.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gender-affirming hormone therapy induces specific DNA methylation changes in blood</article-title>
                  <source>Clin. Epigenetics</source>
                  <year>2022</year>
                  <volume>14</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13148-022-01236-4</pub-id>
                  <pub-id pub-id-type="pmid">34980250</pub-id>
                </element-citation>
              </ref>
              <ref id="CR82">
                <label>82.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Herwig</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Hardt</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Lienhard</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kamburov</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Analyzing and interpreting genome data at the network level with ConsensusPathDB</article-title>
                  <source>Nat. Protoc.</source>
                  <year>2016</year>
                  <volume>11</volume>
                  <issue>10</issue>
                  <fpage>1889</fpage>
                  <lpage>1907</lpage>
                  <pub-id pub-id-type="doi">10.1038/nprot.2016.117</pub-id>
                  <?supplied-pmid 27606777?>
                  <pub-id pub-id-type="pmid">27606777</pub-id>
                </element-citation>
              </ref>
              <ref id="CR83">
                <label>83.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McLeay</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>TL</given-names>
                    </name>
                  </person-group>
                  <article-title>Motif enrichment analysis: A unified framework and an evaluation on ChIP data</article-title>
                  <source>BMC Bioinform.</source>
                  <year>2010</year>
                  <volume>11</volume>
                  <fpage>165</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2105-11-165</pub-id>
                </element-citation>
              </ref>
              <ref id="CR84">
                <label>84.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pelegí-Sisó</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>de Prado</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Ronkainen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bustamante</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>González</surname>
                      <given-names>JR</given-names>
                    </name>
                  </person-group>
                  <article-title>Methylclock: A bioconductor package to estimate DNA methylation age</article-title>
                  <source>Bioinformatics</source>
                  <year>2021</year>
                  <volume>37</volume>
                  <issue>12</issue>
                  <fpage>1759</fpage>
                  <lpage>1760</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa825</pub-id>
                  <?supplied-pmid 32960939?>
                  <pub-id pub-id-type="pmid">32960939</pub-id>
                </element-citation>
              </ref>
              <ref id="CR85">
                <label>85.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Felitti</surname>
                      <given-names>VJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The adverse childhood experiences (ACE) study</article-title>
                  <source>Am. J. Prev. Med.</source>
                  <year>1998</year>
                  <pub-id pub-id-type="doi">10.1016/S0749-3797(98)00017-8</pub-id>
                  <?supplied-pmid 9635069?>
                  <pub-id pub-id-type="pmid">9635069</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
